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ABSTRACT 
 
 
Many athletes consume caffeine for its known ergogenic effects.  Since being 
legitimised by its 2004 removal from the World Anti-Doping Agency prohibited 
list of substances, caffeine’s ability to enhance performance has led to its 
widespread use amongst the athletic population.  However, despite caffeine’s 
prevalence, little research has focused on the effect of caffeine ingestion on 
immune function both at rest and in response to exercise in humans.  
Therefore, the aim of this thesis was to investigate the influence of typically-
used doses of caffeine (typical daily intake in training and competition doses) on 
aspects of innate and acquired immunity in response to prolonged exercise. 
 
At rest both a high (6 mg·kg-1) and low dose (2 mg·kg-1) of caffeine had little 
effect on antigen-stimulated T (CD4+ and CD8+) or natural killer (NK) 
lymphocyte activation, while a high dose of caffeine only increased the number 
of antigen-stimulated NK cells expressing CD69 1 h following caffeine ingestion 
(Chapter 4).  In response to prolonged high intensity continuous cycling both 
high and low doses of caffeine increased the natural state of activation as well 
as the antigen-stimulated activation of NK cells 1 h after exercise cessation 
(Chapters 5 and 6).  However, at the same time-point a high dose of caffeine 
decreased CD4+ and CD8+ cell activation (Chapter 5).  One hour after high 
intensity intermittent shuttle running, a high dose of caffeine attenuated the 
exercise-induced increase in NK cell activation both in terms of the number of 
cells expressing CD69 and their geometric mean fluorescence intensity 
expression of CD69 (Chapter 7).  These effects did not occur in response to 
intermittent exercise when 2 mg·kg-1 caffeine was instead ingested in 3 
repeated doses throughout the day (Chapter 7). 
 
In conclusion, the findings of this thesis demonstrate the complex actions of 
caffeine on antigen-stimulated T and NK lymphocyte activation 1 h after 
prolonged intensive exercise.  However, the biological significance of these 
findings in terms of caffeine’s potential to alter an individuals’ susceptibility to 
infection following prolonged high intensity exercise are yet to be determined. 
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Exercise can have both negative and positive effects on immune function and 
susceptibility to minor illnesses such as upper respiratory tract infections 
(URTI).  These appear to be dependent upon exercise intensity and duration 
(Gleeson, 2007).  It is suggested that the relationship between exercise 
intensity and risk of infection is “J” shaped (Nieman, 1994).  This model 
suggests that while exercise of moderate intensity may increase immune 
function reducing the risk of infection below that of a sedentary individual, 
prolonged high intensity exercise may suppress immune function increasing the 
risk of subsequent infection above sedentary levels.  More recently an “S” 
shaped model of infection risk has been proposed, suggesting that elite athletes 
may have a lower risk of infection than individuals participating in prolonged 
high intensity exercise, as elite athletes may possess an immune system able to 
withstand infection even during severe physiological stress (Malm, 2006).   
 
 
 
Figure 1.1: S shaped curve of infection risk.  Adapted from Malm 2006. 
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There is general agreement within the exercise immunology literature that an 
acute bout of high intensity exercise causes a temporary perturbation in  various 
aspects of immune cell function that usually last between ~3 and 24 h (as 
reviewed in Gleeson, 2007).  Investigators have largely attributed these 
decrements to the hormonal changes that occur in response to intensive 
exercise (such as increased plasma concentrations of adrenaline and cortisol).  
It has been hypothesised that during this “open window” of reduced 
responsiveness, opportunistic bacteria and viruses may gain a foothold, 
increasing the risk of subsequent infection that may account for the apparent 
increased susceptibility to URTI of individuals who exercise intensely (Nieman, 
2000).  However, a direct link between exercise-induced impaired immune 
function in vivo and increased infection risk has yet to be determined.   
 
Caffeine is part of the methylxanthine family of drugs.  This drug is legally and 
socially acceptable and as such is the most commonly used psychoactive 
substance in the world (Fredholm et al., 1999).  A recent large scale survey 
conducted in the UK found that ~90% of individuals surveyed consumed at least 
40 mg of caffeine (equivalent to 1 cup of tea) per day, with a mean daily 
caffeine intake of 241 ± 173 mg (Heatherley et al., 2006).  Daily caffeine intake 
can vary widely between individuals and from country to country.  For example, 
in the Netherlands mean daily caffeine intake is ~400 mg (Fredholm et al., 
1999).  Caffeine between the doses of 3 and 6 mg·kg-1 body mass has 
consistently been shown to enhance athletic performance in high intensity 
continuous (cycling, running etc.) and intermittent (football, rugby etc.) exercise 
(Goldstein et al., 2010).  However, caffeine doses as low as 2 mg·kg-1 body 
mass have also proved ergogenic (Cox et al., 2002). Since being legitimised by 
its 2004 removal from the World Anti-Doping Agency (WADA) prohibited list of 
substances, caffeine’s ability to enhance performance has led to its widespread 
use amongst the athletic population (Chester and Wojek, 2008).  The main 
action of caffeine at physiological concentrations is via antagonism of 
adenosine receptors (Fredholm et al., 1999).  Furthermore, caffeine has been 
consistently shown to increase plasma adrenaline concentration (Graham, 
2001; Bishop et al., 2005a; Walker et al., 2006).  Despite caffeine’s frequent 
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and prominent use within society, very few studies have investigated the effect 
of caffeine on immune cell responses in humans, and in particular following 
exercise.  Therefore, this thesis investigated the effect of caffeine ingestion on 
lymphocyte activation in response to prolonged high intensity exercise. 
 
Firstly the effects of a high (6 mg·kg-1) and low (2 mg·kg-1) dose of caffeine on 
unstimulated and antigen-stimulated T (CD4+ and CD8+) and natural killer (CD3-
CD56+) lymphocyte activation were determined in participants at rest (Chapter 
4).  Once it had been ascertained that caffeine had little effect on these 
parameters at rest, the effect of caffeine ingestion (6 mg·kg-1) on unstimulated 
and antigen-stimulated CD4+, CD8+ and CD3-CD56+ lymphocyte activation was 
determined in response to prolonged intensive exercise (90 min cycle 70% 
peakOV 2& ) as described in Chapter 5.  As caffeine has been shown to affect 
lymphocyte function differentially depending on the dose ingested (Kantamala 
et al., 1990) the effects of a high (6 mg·kg-1) and low (2 mg·kg-1) dose of 
caffeine on unstimulated and antigen-stimulated CD3-CD56+ lymphocyte 
activation in response to prolonged intensive exercise (90 min cycle 70% 
peakOV 2& ) was investigated in Chapter 6.  It has been suggested that studies 
using one single bolus dose of caffeine to investigate the effects of caffeine on 
immune function do not represent normal caffeine consumption patterns 
(Horrigan et al., 2006), as humans tend to ingest caffeine in several doses 
throughout the day (Fredholm et al., 1999).  Therefore, in Chapter 7 we 
investigated whether small repeated doses (2 mg·kg-1) of caffeine ingested 
throughout the day (9:00 h, 12:00 h & 15:00 h) elicited a similar response as 
one large (6 mg·kg-1) bolus dose ingested 1 h prior to exercise (15:00 h) on 
unstimulated and antigen-stimulated CD3-CD56+ lymphocyte activation 
following 90 min of high intensity intermittent exercise. 
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  6   
   
 
  
 
2.1. Are athletes more susceptible to infection? 
It has been proposed within the exercise immunology literature that athletes 
may be more susceptible to infection, particularly URTI, in the hours following 
intensive exercise, due to a temporary depression in a number of immune 
functions (Gleeson, 2007).  Findings from survey-based epidemiological 
research seem to lend support to this notion (reviewed in Moreira et al., 2009), 
and report that in the weeks following competitive endurance events (such as 
marathons/ultramarathons) there is a 100-500% increase in risk of picking up 
an infection (Peters and Bateman, 1983; Nieman et al., 1990).  The risk of 
infection seems to correlate with athletes’ race finishing times (Peters and 
Bateman, 1983) and pre-race training volume (Nieman et al., 1990).   
 
Despite the apparent support from epidemiological research for an association 
between continuous heavy exercise and increased risk of URTI, one must view 
this evidence with caution, as a recent study failed to confirm these findings in a 
large cohort of marathon runners (Ekblom et al., 2006).  The authors reported 
that incidence of post-race infection in the 3 weeks following the race was 
strongly related to pre-race infection in the 3 weeks leading up to the race.  This 
suggests that the increased rate of infection in athletes may be caused by 
strenuous exercise too soon after an infection, allowing a reactivation of the 
virus responsible for the pre-race infection, rather than a depression in immune 
function.  
 
Apart from epidemiological research, it has been well established within 
exercise immunology that acute bouts of prolonged intensive exercise are 
associated with a temporary depression of immune function that appears to last 
~3-24 h (Gleeson, 2007).  This decline in host defence therefore has been 
suggested to be responsible for the proposed increased incidence of URTI 
amongst athletes.  Although this research seems to support the notion that 
intensive exercise may lead to an increased risk of URTI, these studies have 
tended to investigate the effect of strenuous exercise on isolated immune cells 
in vitro, as such a direct link between immune function in vivo and infection risk 
has yet to be established.   
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There are only a few studies that have investigated whether the whole immune 
system’s ability to respond to pathogens following acute prolonged exercise is 
impaired in vivo (Bruunsgaard et al., 1997; Harper Smith et al., 2009).  
Bruunsgaard et al. (1997) reported that triathletes who performed a half 
ironman event (consisting of 3 km swim, 130 km cycle and 21 km run) showed 
a significant impairment of in vivo cell-mediated immunity in the days following 
this bout of high intensity exercise.  The cellular immune response was 
evaluated as a skin test response to 7 recall antigens.  The skin test response 
was significantly lower in the group of triathletes who performed the half 
ironman compared with triathlete controls and moderately trained controls who 
did not participate in the event.  In addition, Harper Smith et al. (2009) have also 
demonstrated that 2 h treadmill running at 60% peakOV 2&  significantly decreased 
in vivo cell-mediated immunity 24 h and 48 h post-trial.  This study used a novel 
contact sensitiser diphenylcyclopropenone. 
 
2.2. Lymphocytes and their role in the immune system 
2.2.1. T cells 
Lymphocytes constitute 20-25% of circulating leukocytes; T cells represent ~60-
75% of this total lymphocyte pool (Gleeson and Bishop, 2005).  T lymphocytes 
are part of the acquired immune system and are responsible for orchestrating 
and participating in a highly specific and long lasting immune response to 
pathogenic invaders.  As such T cells are central elements of the immune 
system (Fabbri et al., 2003).  All T cells selectively express CD3 as well as CD4 
(T helper cells) or CD8 (T cytotoxic/suppressor cells).  T helper cells constitute 
around 60-70% of T lymphocytes, while T cytotoxic cells represent 30-40% 
(Gleeson, 2006).   
 
T helper (TH, CD4+) cells have a central function in the generation, maintenance 
and regulation of both the cell-mediated and humoral arm of the immune 
response (Fabbri et al., 2003).  These cells activate other immune cells to kill 
intracellular targets or to produce antibody.  T cytotoxic (TC, CD8+) cells are 
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responsible for the cytotoxic killing of virus infected cells and some tumour cells.  
Antigen-specific cytotoxic T cells kill infected cells via apoptosis, leading to 
death of the targeted cell via the release of cytotoxic proteins (perforin and 
granzymes) stored in lytic granules (Janeway, 2001).  There is a further subtype 
of T cell, with immunosuppressive functions and cytokine profiles distinct from 
other
 
T cells, termed regulatory T (Treg) cells (McGuirk and Mills, 2002).  Treg 
cells express the CD4+ marker (associated with helper function) as well as 
CD25+, but do not seem to act as classical T helper cells.  They produce 
interleukin (IL)-10 and transforming growth factor (TGF)-β (immunosuppressive 
cytokines) and their primary function appears to be to suppress inflammatory 
and cell-mediated immune responses (McGuirk and Mills, 2002).   
 
TH and TC lymphocytes can be further subdivided into type 1 (TH1 & TC1) or type 
2 (TH2 & TC2) cells based on their distinct profiles of cytokine production 
(Lancaster et al., 2005).  Type 1 T cells produce interferon (IFN)-γ, IL-2 and 
tumour necrosis factor (TNF)-α and have been shown to protect against 
intracellular pathogens.  Type 2 T cells produce IL-4, IL-5, IL-6 and IL-13 and 
defend against extracellular parasites.  It is the release of these cytokines by 
activated TH cells that determines whether cell-mediated (TH1 profile) or humoral 
(TH2 profile) immunity will dominate (Gleeson, 2006).  Developed TH1 and TH2 
cells secrete IFN-γ and IL-4 respectively, in an autrocrine and reciprocally 
inhibitory fashion.  IFN-γ promotes growth of TH1 cells and inhibits the 
proliferation of TH2 cells, while IL-4 has the opposite influence (Liew, 2002). 
 
During maturation in the thymus and later on in secondary lymphoid organs 
(spleen, lymph nodes and mucosal-associated lymphoid tissue) T cells acquire 
the features of specificity of recognition, lack of self reactivity and memory of 
previous antigen encounters, that are physiological hallmarks of T lymphocytes 
(Fabbri et al., 2003).  Being able to distinguish self from non-self is due to a 
polymorphic membrane heterodimer, the T cell receptor (TCR) (Fabbri et al., 
2003).  The TCR recognises foreign antigens that are presented as processed 
peptides, loaded on a heterodimer called the major histocompatability complex 
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(MHC), expressed on the plasma membrane of the antigen presenting cell 
(APC) (Viret and Janeway, 1999). CD4+ cells recognise and respond only to 
MHC class II proteins, while CD8+ cells are restricted by MHC class I proteins, 
thus forming the basis for the functional specialisation of the two major T cell 
subsets (Fabbri et al., 2003). 
 
The primary function of APCs therefore is to stimulate T cells and initiate an 
immune response.  If a mature T cell has not encountered an antigen before, it 
is said to be naïve.  The naïve (CD45RA+) T cell therefore must be introduced 
to the antigen and MHC by a dendritic APC before it can be initiated into the 
rites of a primary immune response (Roitt and Delves, 2001).  However, binding 
of the TCR with peptide:MHC complexes (signal 1) on its own will not stimulate 
T cells to proliferate and differentiate into armed effector T cells.  Antigen-
specific activation and clonal expansion require a second or co-stimulatory 
signal, which must be delivered by the same APC before any type of immune 
response (primary or secondary) can be initiated.  Therefore, co-stimulatory 
molecules on the APC (CD80 and CD86) need to interact with their respective 
counter-receptors (CD28) on T cells (signal 2), at the same time as TCR 
mediated recognition [(signal 1) (TCR engagement with its antigen-MHC 
complex)] (Roitt and Delves, 2001).  Engagement of the TCR signal 1 without 
the accompanying co-stimulatory signal 2 will lead to anergy 
(unresponsiveness) in resting T cells (Roitt and Delves, 2001).  It has been 
suggested that during initial priming of naïve T cells, interaction of the T cell 
CD28 receptor with CD80 on the APC tends to favour a TH1 differentiation, 
whereas interaction of the same receptor with CD86 favours a TH2 differentiation 
(Liew, 2002).  Once a T cell has differentiated into an effector T cell, a co-
stimulatory signal is no longer required in order for this cell to mount an immune 
response upon encounter with its specific antigen (Janeway, 2001). 
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2.2.2. Natural killer cells 
Natural killer (NK) cells are an essential component of the innate immune 
system playing a critical role in defence against viral infection and tumour 
immune surveillance (Cooper et al., 2001).  NK cells are distinct from other 
lymphocytes, as they do not need prior sensitisation or require specific-antigen 
recognition in order to kill target cells (Moretta et al., 2008).  NK cells comprise 
approximately 5-20% of lymphocytes in peripheral blood (Andoniou et al., 2006) 
and have the ability to lyse target cells and/or to secrete immunoregulatory 
cytokines (Cooper et al., 2001).  NK cells can be identified through the use of 
monoclonal antibodies (mab) as they lack expression of CD3, but express 
CD16 and CD56 on their cell surface (Gleeson, 2006).  Two distinct populations 
of human NK cells have been identified through their surface density expression 
of CD56.   The majority (~90%) of human peripheral blood NK cells express low 
levels of CD56 (CD56dim) and high levels of CD16 (CD16+), whereas a minority 
(~10%) are CD56bright and CD16- (Fehniger et al., 2003).  These two subsets 
appear to have distinct functional characteristics and roles in the human 
immune response; resting CD56dim NK cells are thought to be more cytotoxic as 
they contain more perforin, granzymes and cytolyitc granules, while CD56bright 
NK cells have been shown to be superior in producing abundant 
immunoregulatory cytokines once stimulated (Jacobs et al., 2001).  It has been 
suggested that following activation with IL-2 or IL-12 in vitro CD56bright NK cells 
and CD56dim cells have similar levels of cytotoxicity (Cooper et al., 2001).   
 
NK cells do not have the ability to rearrange genes encoding for antigen 
recognition (unlike T cells) but instead have several receptors on their cell 
surface that can be classified as activating/inhibiting receptors that help to 
target and kill virally-infected and abnormal cells (Andoniou et al., 2006).  
Inhibitory receptors engage MHC class I molecules that are found on virtually all 
healthy cells; while activating receptors bind ligands on the target cell surface 
thus triggering NK cell activation and lysis of the target cell (Shereck et al., 
2007).  Cellular ligands for NK cell activating receptors are generally not found 
on healthy cells but may become induced upon cellular stress such as infection 
(Andoniou et al., 2006).   Engagement of the inhibitory receptors will normally 
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override any signals from activating receptors and therefore protect healthy 
cells expressing normal levels of MHC-I from NK cell lysis.  However, in some 
circumstances signals from activating receptors are sufficient to stimulate NK 
cells despite signalling from MHC-I inhibitory receptors (Chambers et al., 1996) 
Cells infected by intracellular pathogens tend to express reduced levels of 
MHC-I; as such infected cells are unlikely to engage NK cell inhibitory receptors 
and leave themselves open to NK cell attack, especially if activating receptors 
are bound by appropriate ligands.  NK cells are also activated by various pro-
inflammatory cytokines, namely IFN-γ, IL-2, IL-12, IL-15 or IL-18, causing an 
increase in their number and cytotoxic activity resulting in their ability to kill a 
broader range of targets (Shereck et al., 2007).  As such the activation of NK 
cells is a very complex balance of activating and inhibitory signals that also 
appears to require the actions of pro-inflammatory cytokines (Andoniou et al., 
2006).   
 
Following activation, NK cells secrete cytokines (IFN-γ, TNF-α) that can control 
the growth and spread of infected cells, as well as alerting the host to the 
presence of an infectious agent.  As such many of the cytokines secreted 
following NK cell activation can affect the initiation and maintenance of adaptive 
immune responses.  As well as the release of cytokines following NK cell 
activation, NK cells can directly kill target cells via apoptosis.  Target cell 
apoptosis occurs via exocytosis of granules that contain perforin and 
granzymes; upon entry into the target cell these molecules induce cell death 
(Andoniou et al., 2006).   
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2.3. Lymphocyte responses to acute exercise 
2.3.1. T and NK cell number 
The circulating number of T and NK lymphocytes tend to show a biphasic 
pattern in response to acute exercise, with a marked increase during and 
immediately after exercise (lymphocytosis) and a significant fall during the early 
stages of recovery (lymphocytopenia) to below baseline values (reviewed in 
Gleeson and Bishop, 2005); the magnitude of which appears to be more related 
to the intensity of the exercise than the duration.  Low (25% max2OV& ) and 
moderate (50% max2OV& ) intensity exercise tend to elicit few changes in 
lymphocyte number, the magnitude of which is nowhere near as pronounced as 
that following high intensity (75% max2OV& ) exercise (Tvede et al., 1993).  For 
example, Nieman et al. (1994) demonstrated that 45 min of treadmill exercise at 
80% max2OV&  resulted in a 70% increase in lymphocyte count immediately 
following exercise, that subsequently fell 48% below pre-exercise levels 1 h 
later.  However, the same duration of exercise at 50% max2OV& had little effect on 
circulating lymphocyte counts.  Tvede et al. (1993) also found similar responses 
following 1 h cycling at 75% max2OV& .  Lymphocyte counts increased immediately 
following exercise but were markedly decreased at 2 h post-exercise.  Again in 
contrast, the same duration of exercise at 25% max2OV& did not change circulating 
lymphocyte counts.  
 
The biphasic response of T cell number to acute strenuous exercise is also 
apparent within the T cell subsets CD4+ and CD8+ (Nieman et al., 1994; 
Steensberg et al., 2001).  It appears that when cell number is adjusted and 
expressed as the percentage change from resting values, the subset of CD8+ T 
cells exhibit a greater relative increase during and immediately following 45 min 
treadmill exercise at 80% max2OV& , with a greater decline during recovery than 
CD4+ T cells (Nieman et al., 1994).  Evidence suggests that the suppression in 
both CD4+ and CD8+ cells during recovery from acute intensive exercise is 
largely due to a decreased percentage of type 1 CD4+ and CD8+ cells 
(Steensberg et al., 2001; Lancaster et al., 2005).  A 50% decrease in the 
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percentage of circulating CD4+ and CD8+ T cells producing IFN-γ and IL-2 (type 
1 cytokines) upon mitogen stimulation has been found immediately and 2 h 
following a 2.5 h treadmill run at 75% max2OV&  compared with pre-exercise 
values; while for the same time-points the percentage of T cells producing IL-4 
(type 2 cytokine) were unchanged (Steensberg et al., 2001).  This study 
suggests that the total decline in CD4+ and CD8+ T cells during recovery from 
exercise is largely due to a decrease in type 1 T cells.  Type 1 T cells are crucial 
in the defence against intracellular pathogens; therefore a significantly impaired 
type 1 T cell response following exercise may be partly responsible for the 
proposed increased risk of URTI after acute strenuous exercise. 
 
NK cells are the most responsive cell type to an acute bout of intensive exercise 
and large increases (~50-500%) in the number of circulating NK cells have 
been shown immediately following exercise.  However, for several hours 
following exercise NK cell numbers tend to drop to less than half of normal 
baseline levels, with normal resting values restored within 24 h (Hoffman-Goetz 
et al., 1990; Gabriel et al., 1991, 1992; Tvede et al., 1993; Shephard and Shek, 
1999).  While many studies have investigated how NK cells respond to acute 
exercise, little research has looked at how different NK cell subsets (CD56bright 
and CD56dim) respond to exercise.  Generally this research has suggested that 
there is a differential mobilisation of NK cell subsets in response to acute 
exercise; the CD56dim NK subset appears to be more responsive immediately 
following exercise than its CD56bright counterpart (reviewed in Timmons and 
Cieslak, 2008).  This differential mobilisation appears to exist for high-intensity 
(~70% max2OV& ) exercise that lasts between 5 and 60 min (Suzui et al., 2005, 
2006; Timmons et al., 2006a,b; Timmons and Bar-Or, 2007).  During the post-
exercise recovery period (up to 1 h) following 60 min cycling at 70% max2OV& , the 
ratio of CD56bright/CD56dim NK cells favours the CD56bright subset (Timmons et 
al., 2006a,b; Timmons and Bar-Or, 2007).  As this subset is naturally less 
cytotoxic than CD56dim NK cells (Jacobs et al., 2001), any increase in this 
subset could lead to a dampening of overall killing capacity and potentially leave 
a host more susceptible to infection following acute intensive exercise. It should 
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be noted that many of the studies that have investigated the effect of exercise 
on NK cell subsets have carried out their research using children and 
adolescents; as such these findings may not be representative of how NK cell 
subsets respond to acute exercise in adults.    
 
2.3.2. Mechanisms underlying mobilisation during and after acute exercise 
Several mechanisms have been proposed to be responsible for the 
lymphocytosis and lymphocytopenia evident during and following exercise, 
respectively.  It has been suggested that the initial increase in circulating 
lymphocyte counts is due to a flushing of cells attached to the endothelium from 
the marginal pool, the spleen and liver (Benschop et al., 1996; Krüger et al., 
2008).  This action is thought to be mediated via mechanical factors such as an 
increase in cardiac output, the shear stress associated with an increased 
pulmonary blood flow as well as a redistribution of blood flow (Foster et al., 
1986).   
 
Others have suggested that the increase in lymphocyte counts during and 
immediately after intensive exercise are due to the effects of catecholamines; 
which are known to increase in response to strenuous exercise (Hartley et al., 
1972; Maisel et al., 1990; Murray et al., 1992; Shephard, 2003).  Lymphocytes 
express a high density of homogenous β2-adrenoreceptors.  Interestingly, 
lymphocyte subsets appear to have a differential density of β2-adrenoreceptors 
(Murray et al., 1992).  CD8+ T cells possess 2-3 times more functional β2-
receptors than CD4+ T cells, while NK cells possess nearly 50% more β2-
receptors than CD8+ T cells (Murray et al., 1992).  Adrenaline is a β2-agonist 
and upon stimulating this receptor induces the formation of intracellular cyclic 
AMP.  Elevations in cAMP concentration via the actions of catecholamines 
therefore may modify the surface expression of adhesion molecules resulting in 
the mobilisation of these cells into the circulation (Maisel et al., 1990; Benschop 
et al., 1997; Nagao et al., 2000; Shephard, 2003).  This mechanism along with 
the differences in the density of β2-adrenoreceptors amongst lymphocyte 
subsets helps to explain why NK cell counts appear to be the most responsive 
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to the affects of exercise and why the relative increase in the number of 
circulating CD8+ T cells is higher during and after exercise compared with CD4+ 
T cells.   
 
It has been suggested that the fall in lymphocyte count during recovery from 
exercise may be due to the trafficking of lymphocytes out of the circulation to 
sites where their immune functions are needed. In support of this notion, Krüger 
et al. (2008) have demonstrated that in response to high intensity exercise T 
cells appear to migrate to sites such as Peyer’s Patches and the lungs and 
have suggested that this accumulation may serve to enhance immune vigilance, 
as these sites represent the body’s major defence barriers.  It has been 
proposed that cortisol may be responsible for the lymphocytopenia that occurs 
following high intensity exercise, as this stress hormone has been shown to 
promote lymphocyte movement out of the vascular compartment into the 
tissues via intravenous administration (Cupps and Fauci, 1982).  Plasma 
cortisol concentrations tend to increase with exercise that is above 60% max2OV&  
(Bishop, 2006a) and have been shown to stay elevated for some time after 
exercise cessation (Nieman, 1997; Steensberg et al., 2001).  Shinkai et al. 
(1996) have also suggested that increased cortisol concentrations following a 
60 min cycle at 60% max2OV&  may have been responsible for the 
lymphocytopenia that occurred 2.5 h following exercise, as participants whose 
cortisol concentrations did not appear to respond to the effects of exercise did 
not demonstrate any such lymphocytopenia.  However, in a study by Bishop et 
al. (2005a), a fall in lymphocyte number during the recovery period following an 
acute bout of high intensity exercise (90 min cycle, 70% max2OV& ) was seen 
without a significant increase in plasma cortisol concentration at this time.  As 
such, these findings suggest that while cortisol may play a significant role in the 
fall of lymphocyte number seen following strenuous exercise, it does not appear 
to be the only mechanism responsible.   
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It should be emphasised that the changes described above refer to alterations 
in T and NK cell number only, not alterations in function.  As such the 
lymphocytosis observed during and immediately following exercise does not 
necessarily lead to an increase in immune function.  Likewise, the 
lymphocytopenia seen during recovery does not necessarily suggest a 
suppressed ability of the host to mount an immune response when faced with 
an antigenic challenge.   
 
2.3.3. Lymphocyte activation 
As previously discussed, cell activation is a crucial first stage that cells need to 
undergo in order to mount a successful immune attack in response to infection.  
Therefore the ability of lymphocytes to become activated has a direct result on 
subsequent lymphocyte functions.   
 
Commitment to cellular activation leads to the expression of newly synthesised 
proteins on the cell surface.  CD69 is the first cell surface glycoprotein detected 
after activation (Ziegler et al., 1994).  Resting (unstimulated) peripheral blood 
lymphocytes do not usually express CD69, with only a small number of 
circulating lymphocyte cells expressing low levels of this marker (Ziegler et al., 
1994; Borrego et al., 1999).  However, Borrego et al. (1999) suggest that even 
the low levels of CD69 expressed on resting lymphocytes are functionally 
active.  Nevertheless, this antigen is rapidly induced on lymphocytes following 
activation, with transcription of CD69 evident within 30-60 min and surface 
expression detectable after 2-3 h (Ziegler et al., 1994).  As such CD69 has been 
classed as a marker of early lymphocyte activation. Once expressed on 
activated lymphocytes, CD69 is believed to act as a co-stimulatory molecule 
leading to subsequent cytokine production, proliferation and cytotoxicity 
(Moretta et al., 1991; Borrego et al., 1999).   
 
A number of studies have assessed the effect of acute intensive exercise on 
lymphocyte activation in vivo/ex vivo (unstimulated) and in response to mitogen 
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stimulation in vitro, by assessing the concentration of T and NK cells expressing 
the early activation marker CD69 (Ronsen et al., 2001; Vider et al., 2001; 
DuBose et al., 2003; Green et al., 2003; McFarlin et al., 2004; Bishop et al., 
2005a; Timmons et al., 2006a, b; Timmons and Bar-Or, 2007).  The effect of 
acute strenuous exercise on the expression of CD69 on T and NK lymphocytes 
is conflicting.   
 
The in vivo/ex vivo unstimulated expression of CD69 on T and NK cells has 
been shown to be unresponsive (Ronsen et al., 2001; Green et al., 2003; 
Bishop et al., 2005a) immediately after high intensity exercise (70-80% max2OV& ) 
lasting around 60-90 min.  However, NK cell CD69 expression has also been 
shown to increase immediately after 60 min of high intensity exercise (70% 
max2OV& ) in both adults and children (McFarlin et al., 2004; Timmons et al., 
2006b; Timmons and Bar-Or, 2007).  DuBose et al. (2003) have also 
demonstrated an increase in the percentage of CD8+ T cells expressing CD69 
immediately following a ~2 mile run in warm weather in military recruits. During 
the hours of recovery after 60-90 min of intensive (70-80% max2OV& ) exercise, 
expression of CD69 on T and NK cells has been reported to show no change in 
expression from baseline values (Ronsen et al., 2001; Green et al., 2003; 
Bishop et al., 2005a; Timmons and Bar-Or, 2007).  However, following the 
same exercise protocol as that described above, the intensity of CD69 
expression on NK cells has been shown to increase 1 h post-exercise 
(Timmons et al., 2006a, b), while the number of NK cells expressing CD69 has 
been shown to decrease 2 h and 4 h after exercise (McFarlin et al., 2004) when 
compared to pre-exercise values.  
 
Mitogen-stimulated in vitro expression of CD69 on T and NK cells appears to be 
unresponsive to single bouts of acute intensive exercise (70% max2OV& ) lasting 
around 1 h (Ronsen et al., 2001; Green et al., 2003).  Vider et al. (2001) have 
demonstrated a decrease in the percentage of mitogen-stimulated CD4+ and 
CD8+ T cells expressing CD69 immediately following exhaustive exercise 
(treadmill run to volitional exhaustion).  However, it should be noted that this 
decrease had already returned to pre-exercise values within 30 min of recovery.  
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The percentage of CD4+ cells expressing CD69 in response to mitogen 
stimulation has also been shown to decrease below pre-exercise values in 
military recruits immediately following a ~2 mile run in warm weather with 
values returning to baseline within 24 h (DuBose et al., 2003).  Moreover, the 
expression of CD69 on mitogen-stimulated T (CD4+ and CD8+) cells was 
significantly lower following exercise in military recruits with exertional heat 
injury, with values still significantly reduced 24 h later (DuBose et al., 2003).   
 
Reasons for the inconsistency in in vivo/ex vivo findings are not readily 
apparent, although differences in exercise duration, overall exercise intensity 
and/or ambient conditions may be responsible.  Alternatively, differences in 
stimulant concentration, time for culture and whole blood vs. peripheral blood 
mononuclear cell (PBMC) cultures may also contribute to some of the 
inconsistency seen amongst in vitro studies.  Most of the studies above that 
stimulated lymphocytes did so with the mitogen phytohaemagglutinin (PHA) 
(Vider et al., 2001; DuBose et al., 2003; Green et al., 2003). However, the 
amount of PHA used to stimulate cultures varied considerably between studies 
from 5-20 µg/ml.    Reddy et al. (2004) have also demonstrated that the time of 
culture is also an important consideration when measuring CD69 expression, as 
this marker has been shown to increase in a time-dependant manner from 3-12 
h following stimulation with 5 µg/ml PHA.  PHA is also a known T cell stimulant 
that has little affect upon NK cells in culture (Vargas et al., 1996).  However, this 
mitogen was used by DuBose et al. (2003) to stimulate NK cells as well as T 
cells and as such may account for why NK cell activation did not appear to 
change following exercise in this study. 
 
There is debate surrounding the relative merits of mitogen vs. antigen-specific 
responses.  Lymphocyte responses are antigen specific (Roitt and Delves, 
2001), therefore the assessment of cell responses to mitogen stimulation in vitro 
may not necessarily provide the most accurate model for the in vivo situation 
(Bishop et al., 2005b).  Mitogens such as PHA stimulate a high proportion of 
circulating lymphocytes that trigger a potent non-specific immune response that 
may result in a large and unrealistic alteration in lymphocyte function (Bishop et 
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al., 2005b).  Antigens initiate a more specific, subtle immune response that is 
likely to occur in vivo (Bishop et al., 2005b).  As such antigen stimulation (rather 
than mitogen) may give a more realistic insight into the effects of prolonged 
exercise on lymphocyte activation. 
 
2.4. Mechanisms of exercise induced alterations in lymphocyte activation 
2.4.1. Adenosine 
Adenosine is a purine nucleoside that is found in free form both in intracellular 
and extracellular compartments, acting as a regulator of tissue function within 
almost every cell of the human body (Blay and Hoskin, 2007; Klotz, 2007).  The 
plasma adenosine concentration in humans at rest is approximately 40-50 
nmol·L-1 (Vizi et al., 2002; Chouker et al., 2005).  However, adenosine 
concentrations dramatically increase when metabolically stressful conditions 
(i.e. trauma or exercise) occur (Haskó and Cronstein, 2004).  It is well known 
that adenosine is produced during exercise due to the increased 
dephosphorylation of adenosine triphosphate.  Although adenosine is rapidly 
cleared by erythrocytes (Heptinstall et al., 2005), plasma concentrations of 
adenosine have been shown to increase in response to exercise (Vizi et al., 
2002; Chouker et al., 2005).   For example, Chouker et al. (2005) found an 
increase in plasma adenosine concentration from 40 nmol·L-1 at rest to 80 
nmol·L-1 following a 4-4.5 h strenuous hike at low altitude.   
 
Adenosine binds to specific cell surface adenosine receptors (Haskó and 
Cronstein, 2004).  There are four clearly defined adenosine receptor subtypes; 
A1, A2A, A2B and A3 (Blay and Hoskin, 2007).  Both A1 and A2A receptors have a 
high affinity for adenosine, while A2B and A3 receptors have a substantially lower 
affinity (Haskó and Cronstein, 2004).  The primary effector of all four subtypes 
of adenosine receptors is adenylyl cyclase, whose action can either be 
stimulated or inhibited depending upon which adenosine receptor is present on 
a cell.  Both A1 and A3 receptors can inhibit adenylyl cyclase and thus reduce 
levels of cAMP, whereas A2A and A2B receptors stimulate adenylyl cyclase 
leading to an increase in cAMP levels.  cAMP is a second messenger that acts 
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as a negative regulator of T cell activation (Grader-Beck et al., 2003).  With few 
exceptions, the actions of cAMP are mediated via cAMP-dependant protein 
kinase A type I (PKAI).    
 
Unactivated human T lymphocytes express A2A, A2B and A3 receptors, all of 
which exhibit increased expression following T cell activation (Blay and Hoskin, 
2007).  The capacity for increased signalling by activated T cells suggests a 
possible feedback role for adenosine in the control of cell-mediated immune 
responses (Lappas et al., 2005; Blay and Hoskin, 2007).  Adenosine receptor 
expression of NK cells has not yet been formally analysed (Blay and Hoskin, 
2007).  However, a study conducted with adenosine receptor agonists (selective 
for each receptor subtype) on human NK cells has led to the conclusion that A1 
and A2 receptors are present on these cells (Priebe et al., 1990). 
 
Adenosine is a potent endogenous anti-inflammatory agent (Cronstein, 1994) 
that has been shown to inhibit T cell activation (Apasov and Stikovsky, 1999; 
Lappas et al., 2005, 2010).  Apasov and Stikovsky (1999) demonstrated that 
adenosine selectively inhibited TCR-induced activation that also blocked the 
upregulation of CD69 on mouse thymocytes.  The authors concluded that the 
inhibitory effects of adenosine were likely due to general inhibition of TCR-
triggered signalling pathways and that this was achieved due to activation of the 
cAMP-dependant pathway via A2A adenosine receptors; as a selective agonist 
of A2A adenosine receptors as well as the cAMP analog db-cAMP were able to 
inhibit TCR-induced activation.  However, this study used a pharmacological 
dose of adenosine (0.1 mM) and as such may not represent the situation in 
vivo.  Lappas et al. (2005) demonstrated that under physiological conditions an 
analog of adenosine (selective A2A agonist ATL146e) at a concentration of 100 
nmol·L-1 (likely to be achieved following strenuous exercise; Chouker et al., 
2005) attenuated the TCR-triggered expression of CD69 on purified murine 
CD4+ T cells following stimulation with the mab anti-CD3 (responsible for 
stimulating TCR-mediated activation).  As such these findings suggest that at 
physiological concentrations adenosine appears to inhibit T lymphocyte 
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activation and subsequent CD69 expression.  The likely mechanism responsible 
for this inhibition involves the binding of adenosine to T cell A2A receptors, that 
subsequently stimulate adenylyl cyclase leading to an increase in cAMP, which 
via PKAI interferes with TCR signal transduction (Blay and Hoskin, 2007).  
 
In comparison to T cells, no study to date has investigated the effect of 
adenosine on NK cell activation and subsequent CD69 expression.  Studies 
have however investigated the effects of adenosine on human NK cytotoxicity 
(Priebe et al., 1990; Raskovalova et al., 2006).  A study by Priebe et al. (1990) 
on human NK cells demonstrated that the adenosine receptors A1 and A2 
(suggested to be present on human NK cells) have opposing effects when it 
comes to cytotoxic activity.  A1 receptors tend to increase cytotoxic activity of 
NK cells, whereas A2 receptors tend to suppress cytotoxic activity.  The likely 
explanation for the opposing effects of the adenosine receptors on NK cells is 
through intracellular cAMP levels, which are known to modulate NK cell function 
(Goto et al., 1983).  It has been suggested that A1 receptors reduce intracellular 
levels of cAMP and therefore stimulate NK cell cytotoxic activity (NKCA), while 
A2 receptors increase intracellular levels of cAMP and tend to inhibit NK cell 
lytic activity (Priebe et al., 1990).  However, a study using lymphokine activated 
killer (LAK) cells generated from A1 and A3 adenosine-receptor deficient mice 
have ruled out any involvement of these receptors in the adenosine-mediated 
inhibition of LAK cytotoxicity (Raskovalova et al., 2005).  Raskovalova et al. 
(2006) have found that the metabolically stable analog of adenosine (2-
chloroadenosine) inhibits the cytotoxic activity of human NK cells.  However, 
preincubation of NK cells with an A2A receptor antagonist blocked the inhibitory 
effects of 2-chloroadenosine. This study demonstrates that the inhibitory actions 
of adenosine on NK cells are mediated via A2A receptors, which activates 
adenylyl cyclase and stimulates cAMP production that activates PKAI that 
transmits a signal leading to an inhibition of NK cytotoxicity. 
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2.4.2. Adrenaline 
Adrenaline is a catecholamine that is derived from the amino acids 
phenyalanine and tyrosine.  Adrenaline concentration at rest is relatively low 
(0.1 nmol·L-1).  However, in response to physical stress such as high intensity 
exercise adrenaline concentration has been consistently shown to increase 
significantly from resting values; with values close to 3 nmol·L-1 being recorded 
following exercise to exhaustion (Hartley et al., 1972; Graham and Spriet, 1995; 
Walker et al., 2008).  It should be noted that while increases in adrenaline 
concentration are also evident at more moderate intensities of exercise (50% 
max2OV& , 0.55 nmol·L-1), once exercise exceeds 70% max2OV&  there is an 
exponential increase in plasma concentrations of adrenaline (Shephard, 2003).   
 
Adrenaline mediates its effects on target cells via stimulation of either α- or β-
adrenoreceptors.  Lymphocytes have been shown to express a homogenous 
population of β2-adrenoreceptors (Murray et al., 1992).  As previously described 
(section 2.3.2) NK, CD8+ and CD4+ T cells differ in their density of β2-receptors, 
with NK cells having the greatest number of receptors and CD4+ T cells the 
lowest (Maisel et al., 1990).  Exercise and catecholamine exposure have been 
shown to increase the density of these receptors (Shephard, 2003).  In general, 
β2-adrenoreceptors activate adenylate cyclase that increases intracellular 
cAMP.  cAMP executes its effects through activation of PKAI and as such acts 
to inhibit lymphocyte activation (Grader-Beck et al., 2003).  Both NK cells and 
CD8+ T cells are very responsive to β2-adrenoreceptor stimulation with regard to 
cAMP accumulation, while CD4+ cells only appear to show a moderate 
response (Maisel et al., 1990).   
 
Shimamiya et al. (2003) have shown that at physiological concentrations 
adrenaline inhibits CD69 expression on mitogen-stimulated T and NK 
lymphocytes and that this suppression can be blocked by the non-selective β-
antagonist propranolol.  As β2-receptor activation via adrenaline increases 
intracellular cAMP it seems plausible that the mechanisms responsible for the 
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inhibition of both natural and mitogen-stimulated lymphocyte activation via 
adrenaline are similar to those of A2A receptor activation via adenosine.  
 
Additionally, increases in natural lymphocyte activation following strenuous 
exercise (McFarlin et al., 2004; Timmons et al., 2006b) could reflect an 
adrenaline-mediated mobilisation of a specific population of lymphocytes into 
the circulation with an activated phenotype.  As previously described (section 
2.3.2) adrenaline via β2-adrenoreceptor activation is thought to modulate the 
expression of adhesion molecules on lymphocytes, leading to an increase in 
circulating lymphocyte number following either exercise or adrenaline infusion 
(Kappel et al., 1991).  Timmons et al. (2006b) showed a significant increase in 
adrenaline concentration and number of NK cells expressing CD69 immediately 
following 60 min cycling at 70% max2OV& .  The increase in number of NK cells 
expressing CD69 most likely reflected a recruitment of NK CD69+ cells into the 
circulation as the increase in activated cells corresponded with post-exercise 
lymphocytosis.  As well as this, the NK cell CD69 expression on a per cell basis 
did not increase in response to exercise.   
 
2.5. Caffeine 
The effect of caffeine ingestion on lymphocyte activation in humans either at 
rest or following exercise has not been extensively studied.  Caffeine ingestion 
however has been consistently shown to increase plasma adrenaline 
concentration (Graham and Spriet, 1995; Graham, 2001; Bishop et al., 2005a; 
Walker et al., 2006).  Furthermore, the main action of caffeine at concentrations 
relevant to normal patterns of consumption is via antagonism of adenosine 
receptors (Fredholm et al., 1999).  Caffeine is very similar in structure to 
adenosine and as such can bind to cell membrane receptors for adenosine, 
thus blocking their action (Graham, 2001).  Therefore, caffeine has the potential 
to modulate lymphocyte activation either directly via adenosine receptor 
antagonism or indirectly via stimulation of adrenaline release.  
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Caffeine is a member of the methylxanthine family of drugs.  It is a trimethyl 
purine base, methylxathine (1, 3, 7- trimethylxathine) with a molecular weight of 
194.2 (Mandel, 2002).  Caffeine is a chemical substance that has been 
identified in around 60 plants and is obtained as a white, odourless, crystalline, 
bitter tasting powder (Debry, 1994).  This drug is legally and socially accepted, 
and as such is the most widely consumed psychoactive substance in the world 
(Graham, 2001).  Caffeine is a common element in most people’s diets 
(Heatherley et al., 2006), yet it is not a typical nutrient nor is it essential for 
health (Graham, 2001).  It is estimated that the mean daily intake of caffeine in 
the UK is ~241 ± 173 mg·day-1, which is the equivalent to around 2-4 cups of 
coffee (Heatherley et al. 2006).  However, daily caffeine intake can vary widely 
from person to person and country to country. For instance the daily caffeine 
intake in Sweden and Norway is more like 400 mg·day-1 (Fredholm et al., 1999).  
The main sources of caffeine within a person’s diet are in the form of coffee, 
tea, cocoa beverages, chocolate, soft drinks, energy drinks and several drug 
preparations (Mandel, 2002).  Table 2.1 shows the caffeine content of common 
caffeine-containing products.   
 
Table 2.1: Caffeine content of common caffeine-containing beverages and 
foods 
 Source (serving size) Caffeine content (mg) 
 Coffee (150 ml) * 50-120  
 Tea (150 ml) * 15-50 
 Coca-cola (330 ml)   30 
 Energy drinks (250 ml)   80 
 Hot chocolate (250 ml)   10 
 Chocolate bar (50 g)   40 
 Pro Plus (1 capsule)   50 
Caffeine content obtained from Maughan, 2002. * Large variation in caffeine content due to 
source and preparation of product.   
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Caffeine absorption from the gastrointestinal tract is rapid and reaches 99% in 
humans in about 45 minutes following ingestion (Fredholm et al., 1999).  Peak 
plasma caffeine concentration is generally reached between 15 and 120 min in 
humans and as such suggests that there are large interindividual differences in 
response to caffeine ingestion (Fredholm et al., 1999; Desbrow et al., 2009).  
The rate of caffeine metabolism is also variable and as such the plasma half-life 
of caffeine can range from 2-12 h in healthy adults.  However, on average the 
half-life of caffeine in humans is 4-6 h (Benowitz, 1990).  Caffeine is extensively 
metabolised, initially by the liver, which demethylates this trimethylxanthine to 
three dimethylxanthines: paraxanthine (the major primary metabolite), 
theophylline and theobromine, which are then further catabolised (Benowitz, 
1990).  Although paraxanthine and theophylline are also potent adenosine 
antagonists, these metabolites do not appear to increase in the circulation to a 
concentration considered active during caffeine metabolism (Graham and 
Spriet, 1995).  It appears that caffeine pharmacokinetics are not affected by 
exercise or dehydration and is similar between males and females (Graham, 
2001; Goldstein et al., 2010). 
 
2.6. Caffeine and its relevance within sport 
It is commonly reported in the research literature that caffeine between the 
doses of 3-6 mg·kg-1 body mass enhances athletic performance (Goldstein, 
2010), with doses as low as 2 mg·kg-1 body mass also proving ergogenic (Cox 
et al., 2002).  This enhancement has been demonstrated in activities that last as 
little as 60 seconds or as long as 2 hours (Graham, 2001), and helps to explain 
why caffeine is consumed by a variety of athletes from different sporting 
disciplines (Chester and Wojek, 2008).   
 
Many athletes consume caffeine for its known ergogenic effects, with its 
prevalence increasing amongst the athletic population since being legitimised 
by its 2004 removal from the WADA prohibited list of substances (Chester and 
Wojek, 2008).   
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2.7. Caffeine and lymphocyte function at rest 
A number of studies (in vitro and in vivo) conducted have demonstrated that 
caffeine can modulate various aspects of lymphocyte function (as reviewed in 
Horrigan et al., 2006).  Of the research that has been conducted, very few 
studies have used physiological caffeine concentrations that are relevant to 
normal human consumption and even fewer have concentrated on human 
subjects (Horrigan et al., 2006).  The typical plasma concentration of caffeine 
after ingestion of physiological doses (<10 mg·kg-1) appears to increase in a 
dose-dependant fashion and has consistently been reported to be less than 70 
µM (Graham and Spriet, 1995; Fredholm et al., 1999; Mandel, 2002).  Knowing 
the likely plasma concentration following oral caffeine ingestion is particularly 
useful to in vitro studies examining caffeine exposure.  Therefore, based on the 
estimates of plasma caffeine concentration, studies employing 70 µM or less of 
caffeine may be viewed as relevant to human caffeine consumption (Graham, 
2001).   
 
2.7.1. In vitro studies 
Kantamala et al. (1990) demonstrated that caffeine, at a concentration of 20-
100 µM had no effect on NK cell cytotoxicity in rats.  Caffeine at a concentration 
of 50-100 µM has been shown to suppress lymphocyte proliferation in response 
to mitogen stimulation in both rats and humans, whilst a lower dose of caffeine 
(20 µM) had no effect (Kantamala et al., 1990; Horrigan et al., 2005). 
 
2.7.2. In vivo studies 
Kantamala et al. (1990) observed that caffeine consumed consistently for 120 
days produced differential effects on NK cytotoxicity and mitogen-stimulated T 
cell proliferation depending on the dose administered.  They found that doses of 
2 and 18 mg·kg-1·day-1 caffeine had no effect at altering NK cell cytotoxicity, 
while a dose at 6 mg·kg-1·day-1 caffeine tended to reduce NK cell cytotoxicity in 
rat spleen cells.  Likewise, a 2 and 6 mg·kg-1·day-1 dose of caffeine had no effect 
on PHA-P stimulated T cell proliferation within rats, while 18 mg·kg-1·day-1 
caffeine led to an increase in PHA-P stimulated T cell proliferation.  Therefore, 
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this study demonstrates the equivocal nature of the effects of caffeine on 
lymphocyte function.   
 
When interpreting results from in vivo studies it should be kept in mind that most 
of the studies investigating the physiological effects of caffeine have been 
carried out on rodents.  Therefore, when trying to extrapolate data from rodents 
to humans, consideration as to the dose equivalence between species is 
required.  It has been suggested that caffeine doses up to 20 mg·kg-1 in rodents 
are within human physiological concentrations (Horrigan et al., 2006).  It should 
also be taken into account that there are significant differences in caffeine 
metabolism and the plasma half-life of caffeine (rodents: 0.7-1.2 h vs. humans: 
4-6 h) between rodents and humans that may limit extrapolation of findings from 
non-human models.   
 
2.8. Caffeine and lymphocyte activation following exercise 
To the author’s knowledge only one study to date has investigated the effect of 
caffeine ingestion on lymphocyte activation in response to exercise (Bishop et 
al., 2005a).  Bishop et al. (2005a) reported that caffeine ingestion (6 mg·kg-1) 1 
h prior to exercise increased the percentage of CD4+ and CD8+ cells expressing 
CD69 both prior to and following 90 min cycle exercise at 70% peakOV 2& .    
Although this study showed an increase the natural state of activation of CD4+ 
and CD8+ cells both before and after strenuous prolonged exercise with prior 
caffeine ingestion; this study did not stimulate cells with an antigen and as such 
may not represent what actually happens when faced with an antigenic 
challenge.   
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2.9. Potential effects of caffeine on lymphocyte activation following 
exercise 
Plasma adenosine concentration dramatically increases during periods of 
stress, such as exercise (Vizi et al., 2002; Chouker et al., 2005).  Caffeine is a 
non-selective adenosine antagonist, with preferential A1 and A2A receptor 
antagonism (Ferre et al., 2008).  Following intravenous caffeine infusion, 
plasma adenosine concentration has been shown to increase in a dose-
dependant manner that is thought to be due to receptor blockade (Conlay et al., 
1997).  Adenosine is known to inhibit T cell activation and CD69 expression as 
well as NK cell cytotoxicity (see section 2.4.1).  Therefore it seems plausible 
that caffeine could inhibit the occupancy and/or action of adenosine on 
lymphocyte activation.  Caffeine is also known to stimulate the release of 
adrenaline and as such increase plasma adrenaline concentration (Graham, 
2001).  Adrenaline is a known β2-adrenoreceptor agonist and upon stimulating 
this receptor on lymphocytes has been shown to inhibit expression of CD69 
(see section 2.4.2).  It is likely that in response to caffeine ingestion and 
exercise both mechanisms will be involved.  However, the overall effect on 
lymphocyte activation may depend upon which mechanism dominates.  A 
summary of the potential mechanisms by which caffeine may influence 
lymphocyte activation are outlined in Figure 2.1. 
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Figure 2.1: A summary of proposed mechanisms by which caffeine 
influences lymphocyte activation. 
Caffeine 
LYMPHOCYTE ACTIVATION 
Caffeine 
T cells NK cells 
Adenosine A2A receptor antagonism 
Adenosine A1 
receptor antagonism 
  +ve effect 
-ve effect 
D
ire
ct
 
e
ffe
ct
 
o
f c
a
ffe
in
e 
In
di
re
ct
 
e
ffe
ct
 
o
f c
a
ffe
in
e 
Induces the increased release of adrenaline 
Adrenaline stimulates β2-adrenoreceptors on 
T and NK lymphocytes 
-ve effect 
Increases cAMP 
Decreases cAMP 
Increases cAMP 
  30   
   
 
  
 
2.10. Thesis aims and hypotheses 
The aim of this thesis was to investigate the influence of typically-used doses of 
caffeine (typical daily intake during training and competition doses) on antigen-
stimulated lymphocyte (T cells – acquired immunity and NK cells – innate 
immunity) activation in response to prolonged exercise. 
 
 
It was hypothesised that: 
 
• A high (6 mg·kg-1) and low (2 mg·kg-1) dose of caffeine would have little 
effect on T or NK cell activation compared with placebo in response to 
antigen stimulation during 3.5 h rest. 
 
• A high (6 mg·kg-1) dose of caffeine ingested 1 h prior to exercise would 
increase T and NK cell activation in response to antigen stimulation 
compared with placebo following 90 min cycling at 70% peakOV 2& . 
 
• A high (6 mg·kg-1) dose of caffeine ingested 1 h prior to exercise would 
increase antigen-stimulated NK cell activation to a greater extent than a 
low (2 mg·kg-1) dose of caffeine compared with placebo and as such 
demonstrate a dose-response effect of caffeine following 90 min cycling 
at 70% peakOV 2& . 
 
• Caffeine ingested in small (2 mg·kg-1) repeated (3 doses ingested 3 h 
apart) doses throughout the day would increase antigen-stimulated NK 
cell activation to a similar extent as one large (6 mg·kg-1) bolus dose of 
caffeine ingested 1 h prior to exercise compared with placebo following 
90 min intermittent shuttle running. 
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 Chapter 3 
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3.1. Ethical Approval 
All study protocols presented in this thesis were approved by Loughborough 
University Ethical Advisory Committee.  All participants were fully informed 
about the rationale for the particular study and the design of the exercise tests 
and trial protocol, along with their possible risks and discomforts, both verbally 
and in writing.  Following an opportunity to ask any questions, participants 
provided written informed consent (Appendix A).   
 
Participants completed an extensive health-screening questionnaire (Appendix 
B) along with a physical activity questionnaire (Appendix C) during their initial 
visit to the laboratory to ascertain if they were suitable for the study.  Any 
participants that were currently on medication or had reported symptoms of 
infection in the 4 weeks prior to the study were excluded.  Participants’ habitual 
caffeine consumption was also recorded at the beginning of each study using a 
caffeine consumption questionnaire (Appendix D) to classify participants as low, 
moderate or high habitual caffeine users.  On the day of each main trial, a 
subsequent health-screening questionnaire (Appendix E) was administered to 
confirm that participants were not experiencing any symptoms of URTI and 
were happy to take part in the study.   
 
3.2. Exploratory Methods 
Before the main trials of this thesis began, preliminary tests were carried out to 
ensure that the protocol and methodology of the studies was sound.  The 
Pediacel vaccine (Sanofi Pasteur MSD Ltd, Berkshire, UK) containing diphtheria 
toxoid, tetanus toxoid, acellular pertussis bacteria, poliovirus and haemophilus 
influenza type B was chosen as the stimulant for this thesis. The vaccine was 
initially titrated in order to assess both optimum (1:4000) and sub-optimum 
(1:8000) doses for cell stimulation in culture (Appendix F).  Stimulant 
concentrations were chosen to elicit a maximal lymphocyte response (optimum 
dose) as well as a response likely to occur upon initial infection, when small 
numbers of pathogen enter the body (sub-optimum).  Initially during testing of 
the caffeine (6 mg·kg-1 dose) and exercise trials, blood that was being used to 
set up cell cultures was collected into lithium heparin tubes and put immediately 
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on a mixer.  It soon became apparent that this part of the protocol was flawed, 
as too few cells were being detected by the flow cytometer.  Therefore, cells 
were dying at some point between blood collection and flow cytometer 
acquisition.   
 
Analysis of the published literature using similar methodology suggested that a 
solution to this problem was to change the blood containers from a lithium 
heparin tube to a tube containing sodium heparin, and to place blood samples 
immediately on ice after draw (Vider et al., 2001; Green et al., 2003).  To ensure 
that the changes to the protocol had been successful, blood was collected into 
sterile bijou tubes containing sodium heparin prior to and following 90 min of 
cycle exercise at 70% peakOV 2&  without caffeine ingestion. Samples were 
immediately placed on ice after draw and rolled for 20 min before being 
assessed for T and NK cell number and their expression of CD69 (for full details 
of staining and analysis see 3.6.3).  Unstimulated, optimum and sub-optimum 
cultures were also set up as described below (see 3.6.2) and incubated for 20 h 
at 37°C, 5% CO2.  Following the 20 h incubation, samples were again assessed 
for T and NK cell number and their expression of CD69.  This work 
demonstrated that the total number of T and NK cells that were viable before 
incubation were still present the next day when being acquired (Appendix G).   
 
The new protocol was then tested on blood collected at rest with or without prior 
caffeine ingestion.  Blood samples were taken at 8:30 h, 11:00 h and 12:00 h to 
coincide with some of the time points for the main exercise trials of this thesis 
(pre-supplement, post-exercise and 1 h post-exercise). The protocol was then 
tested on blood collected at pre-supplement, post-exercise and 1 h post-
exercise from a caffeine and exercise trial identical to the ones in Chapters 5 
and 6.   This work helped to ensure that regardless of the trial, cells remained 
viable and could be acquired and that the CD69 marker was detectable 
(Appendix G).  For all trials, participants followed the same standardisation of 
pre-trial conditions as that described below (see 3.4); and for all of the caffeine 
trials, a 6 mg·kg-1 dose of caffeine was selected to try and elicit a stronger and 
more identifiable response.   
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3.3. Preliminary testing 
Approximately 2 weeks before the beginning of the main trials, each participant 
was required to perform a continuous incremental exercise test to volitional 
fatigue on an electromagnetically braked cycle ergometer (Lode Excalibur, 
Groningen, Netherlands), to determine their peak oxygen consumption 
( peakOV 2& ).  Participants started cycling at a work rate of 95 W, with 35 W 
increments every 3 min, continuing until they reached volitional exhaustion.  
Verbal encouragement was given to participants to ensure a maximum effort. 
Maximal work rate (Wmax) was determined according to the following formula: 
Wmax = Wout + (t/180) * 35, where Wout is the last completed stage and t is 
the time in seconds in the final stage (Jeukendrup et al., 1996).  Expired gas 
samples were collected into Douglas bags during the 3rd min of each work rate 
increment and the last min of the exercise test, with heart rates being measured 
continuously via short-range radio telemetry (Polar FS1, Polar Electro Oy, 
Kempele, Finland).  A paramagnetic O2 analyser (Servomex 1420B, 
Crowborough, UK) and an infrared CO2 analyser (Servomex 1415B) were used 
to measure the percentages of O2 and CO2 within the expired gas samples.  
The analysers along with a dry gas meter (Harvard Apparatus, Edenbridge, UK) 
were used to determine minute ventilation, O2 consumption and CO2 production.  
A work rate equivalent of 70% peakOV 2&  for each participant was interpolated from 
the 2OV& (l·min-1) – work rate (W) relationship.   
 
Participants then came back into the lab on a separate occasion to undertake a 
familiarisation trial.   The familiarisation trial required participants to cycle for 90 
min at 70% peakOV 2&  on an electromagnetically braked cycle ergometer.  Heart 
rate was monitored continuously during the familiarisation trial and 1 min 
expired gas samples were collected at 20 min intervals throughout to ensure 
participants were exercising at the correct intensity.  If the participant was 
exercising at an intensity below 65% peakOV 2&  or above 75% peakOV 2&  the work 
rate was adjusted accordingly. 
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3.4. Standardisation of pre-trial conditions 
Each participant was given a list of caffeine containing foods and beverages 
and instructed to abstain from these for 60 h preceding each main trial.  
Participants were also instructed to avoid alcohol consumption and strenuous 
physical activity in the 24 h preceding each experimental trial. In order to 
standardise nutritional status, participants completed a 24 h food diary the day 
before the first main trial and were asked to follow this during the 24 h 
preceding the second (Chapters 4, 5, 6) and third (Chapters 4, 6) main trials. 
 
For each trial, participants arrived at the laboratory following an overnight fast of 
12 h.  Participants were instructed to ingest ~300 ml water upon waking to 
standardise their hydration status prior to each exercise bout.  
 
3.5. Experimental trial procedures 
In the experimental trials of Chapters 4-6, the method of caffeine administration 
was identical.  In Chapter 5, participants ingested 0 or 6 mg·kg-1 body mass of 
caffeine (powder form; BDH Laboratory Supplies, Poole, UK) taken in the form 
of cellulose capsules (G & G Food Supplies Ltd, West Sussex, UK) with 300 ml 
plain water.  For the 0 (placebo) trial, participants ingested 6 mg·kg-1 body mass 
of dextrose powder (BDH Laboratory Supplies, Poole, UK).   In Chapters 4 and 
6 participants also ingested 0 or 6 mg·kg-1 body mass of caffeine, as well as a 2 
mg·kg-1 body mass dose of caffeine administered in the same way. 
 
For Chapters 5 and 6 the mode of exercise was cycling performed using an 
electromagnetically braked cycle ergometer.  Participants’ favoured saddle 
height, handle bar distance from saddle and height were all recorded on their 
first visit to the lab to optimise cycling performance and comfort.  All these 
parameters were then set prior to each additional visit to speed up the transition 
time from rest to exercise. 
 
For the studies described in Chapters 5 and 6 participants arrived at the 
laboratory at 08:20 h.  After 10 min of resting quietly an initial (pre-supplement) 
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blood sample was obtained from an antecubital forearm vein by venepuncture.  
Following the blood collection, participants ingested caffeine or placebo 
(dextrose) powder taken in the form of cellulose capsules with 300 ml plain 
water.  Participants then rested quietly in the laboratory for 1 h before a further 
(pre-exercise) venous blood sample was taken, after which participants’ pre-
exercise body mass (in shorts only) was recorded.  Immediately after this, 
participants began cycling on an electromagnetically braked cycle ergometer for 
90 min at a work rate equivalent to 70% peakOV 2& .  During the 90 min cycle, 
participants’ heart rate and subjective ratings of perceived exertion (RPE) were 
recorded every 15 min. Participants also consumed 2 ml·kg-1 body mass of 
plain water every 15 min throughout the exercise to standardise fluid intake.  At 
20, 50 and 80 min of exercise, 1 min expired gas samples were collected to 
determine 2OV&  and 2COV&  to ensure that participants were exercising at the 
required intensity and to allow estimation of fat and carbohydrate (CHO) 
oxidation as well as energy expenditure using stoichiometric equations 
(Peronnet and Massicote, 1991).  A further venous blood sample (post-
exercise) was obtained immediately after cessation of 90 min exercise, before 
post-exercise body mass (in shorts only) was recorded.  Participants then 
consumed 5 ml·kg-1 body mass of plain water and rested quietly in the 
laboratory for a further hour before a final venous blood sample (1 h post-
exercise) was obtained.  During this time no additional food or fluid was 
administered to participants. 
 
3.6. Blood sampling and analysis 
All blood samples in this thesis were collected by venepuncture from an 
antecubital forearm vein with the participant in an upright seated position.  For 
all samples, approximately 20 ml of blood was collected into three evacuated 
monovette tubes (Starstedt, Leicester, UK), one containing tripotassium 
ethylene diamine tetraacetic acid (K3EDTA) (1.6 mg EDTA ml-1 blood), one 
containing lithium heparin (16 IU heparin ml-1 blood), and one containing no 
additive to obtain serum, as well as a sterile 5 ml bijou tube (Sterilin, 
Staffordshire, UK) containing 15 µl sodium heparin (15 IU heparin ml-1 blood).   
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3.6.1. Haematological analysis 
Blood collected into the K3EDTA monovette (7.5 ml) was analysed for total and 
differential leukocyte counts, haematocrit and haemoglobin contents using a 
haematology analyser (AC.TTM 5diff analyser, Beckman Coulter, UK).  All cell 
counts were adjusted for plasma volume changes in relation to values from the 
initial (pre-supplement) blood sample, with changes being estimated from 
haemoglobin and haematocrit values according to Dill and Costill (1974). 
 
3.6.2. Lymphocyte culture 
Five ml of whole blood transferred into the sterile bijou tube containing sodium 
heparin was immediately placed on ice and mixed (Thermo Denley, Spiramix) 
for 20 min before setting up cultures as follows: Cells were cultured in Falcon 12 
x 75 mm-polystyrene tubes with caps (Becton Dickinson Biosciences, Oxford, 
UK), and for all samples unstimulated and stimulated cultures were set up.  The 
tubes were stimulated by a 1:400 or 1:800 Pediacel working vaccine.  Zero or 
20 µl of Pediacel working vaccine (either 1:400 or 1:800) was added to 200 µl of 
heparinised whole blood, giving a final stimulant concentration of 0 
(unstimulated), 1:4000 (optimum) or 1:8000 (sub-optimum), before being 
incubated for 20 h at 37°C, 5% CO2. 
 
3.6.3. Assessment of lymphocyte subsets and CD69 expression 
After 20 h incubation, peripheral blood cells were labelled with a cocktail of 
Pharmingen monoclonal antibodies (Becton Dickinson Biosciences, Oxford, UK) 
against human lymphocyte cell surface markers, as follows: 5 µl fluorescein 
isothiocyanate (FITC) conjugated anti-CD4, 5 µl R-phycoerythrin-Cy5 (PE-Cy5) 
conjugated anti-CD8 and 10 µl phycoerythrin (PE) conjugated anti-CD69.  The 
other mixture contained 5 µl FITC conjugated anti-CD3, 20 µl PE-Cy5 
conjugated anti-CD56 and 10 µl PE conjugated anti-CD69.  All stained and 
unstained samples were then vortexed and placed on ice for 20 min, after which 
erythrocytes were lysed and leukocytes fixed using FACS Lyse (Becton 
Dickinson, Oxford, UK).  Leukocytes were then washed once in 3 ml ice cold 
phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin (BSA) 
and 2 mM EDTA (PBS/BSA/EDTA) before being resuspended in 400 µl 
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PBS/BSA/EDTA.  Three-colour flow cytometric analysis was performed using a 
FACS Calibur flow cytometer with Cell Quest analysis software (Becton 
Dickinson, Oxford, UK).  Standard gating procedures using side scatter versus 
forward scatter plots were used to gate on the lymphocyte population.  An 
unstained unstimulated sample was used to set quadrant boundaries to allow 
accurate acquisition of stained unstimulated samples. This procedure was 
repeated with unstained stimulated samples for both 1:4000 and 1:8000 stained 
stimulated samples.  All samples were set to collect 30,000 lymphocyte events 
per analysis.   
 
CD4+ and CD8+ populations were acquired on quadrant dot plots of FL1 (CD4 
FITC) and FL3 (CD8 PE-Cy5), along with quadrant dot plots of FL1 (CD4) and 
FL2 (CD69 PE) and quadrant dot plots of FL3 (CD8) and FL2 (CD69).  This data 
was then displayed as histogram plots and the percentage of T cells expressing 
CD4 and CD8bright were derived.  CD8+bright cells were analysed rather than all 
CD8+ cells to avoid inclusion of CD3-CD8+ cells (Campbell et al., 2008).  CD3+ 
(T cell region) and CD56+ (NK cell region) populations were acquired on 
quadrant dot plots of FL1 (CD3 FITC) and FL3 (CD56 PE-Cy5), along with 
quadrant dot plots of FL1 (CD3) and FL2 (CD69 PE) and quadrant dot plots of 
FL3 (CD56) and FL2 (CD69).  This data was then displayed as histogram plots 
and the percentage of CD3- cells (total lymphocyte region minus the CD3+ 
region) expressing CD56+ were derived and from this the percentage of total 
lymphocytes that were CD3-CD56+ was determined.  CD4+, CD8+bright and CD3-
CD56+ cells were then gated into separate regions and CD69+ histogram plots 
of the cells within each of these regions was used to calculate the percentage 
expression and geometric mean fluorescence intensity (GMFI) expression of 
CD69 of CD4+, CD8+ bright and CD3-CD56+ cells. Cell counts of CD4+, CD8+bright 
and CD3-CD56+ were calculated by multiplying the percentage of these cells 
with the absolute lymphocyte count.  The number of lymphocyte subsets 
expressing CD69 were determined by multiplying the percentage of cells 
expressing CD69 by the total number of CD4+, CD8+ bright and CD3-CD56+ cells.  
To facilitate intersubject comparisons, pre-exercise, post-exercise and 1 h post-
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exercise CD69 GMFI were expressed as a percentage of the pre-supplement 
value, as according to Timmons et al. (2006a,b). 
 
3.6.4. Serum caffeine and plasma catecholamines 
Serum was obtained from whole blood collected into a serum monovette (5.5 
ml), which was left to clot for 1 h before being centrifuged at 1500 g for 10 min 
in a refrigerated centrifuge at 4 ºC.  Serum was then evenly distributed into 
labelled eppendorfs and frozen at -80 ºC.  Serum caffeine concentration was 
determined using a commercially available kit (Emit Caffeine Assay, Dade-
Behring, Milton Keynes, UK) on an automatic photometric analyser (COBAS 
Miras Plus, Roche Diagnostic Systems, Switzerland).  The intra assay 
coefficient of variation for serum caffeine was 2.5 %.  Heparinised plasma was 
obtained from blood collected into a lithium heparin monovette (7.5 ml).  
Samples were spun at 1500 g for 10 min in a refrigerated centrifuge at 4 ºC 
within 5 min of collection.  Two ml of the heparinised plasma obtained was 
immediately added to chilled tubes, containing 200 µl of antioxidant 
preservative (pH 6.5) comprising of reduced glutathione (100 mmol·L-1) and 
ethylene glycol tetraacetic acid (100 mmol·L-1).  Plasma and antioxidant were 
mixed and frozen at -80 ºC for later determination of plasma adrenaline and 
noradrenaline concentration by high performance liquid chromatography with 
electrochemical detection, as previously described (Forster and Macdonald, 
1999).  
 
3.7. Statistical analysis 
All statistical analysis was conducted using SPSS 16.0 software for Windows 
(SPSS Inc. Chicago IL, USA).  Data in the text, tables and figures are presented 
as mean values and their standard deviation (± SD).    The data were examined 
using a two-factor (trial x time) analysis of variance (ANOVA) with repeated 
measures design.  If the data were not normally distributed, statistical analysis 
was carried out on the logarithmic transformation of the data.  Assumptions of 
sphericity in the data were checked, and adjustments in the degrees of freedom 
for the ANOVA were made using the Huynh-Feldt method of correction where 
appropriate.  Any significant data were assessed using Student’s paired t-tests 
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with Holm-Bonferroni adjustments for multiple comparisons.  Single 
comparisons between trials for overall exercise intensity, carbohydrate and fat 
oxidation rates, rate of energy expenditure and percentage contribution of 
substrate to energy expenditure were assessed using Student’s paired t-tests.  
Statistical significance for this study was accepted at P<0.05.  The observed 
powers of the reported main and interaction effects are all >0.8.   
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       The effect of a high and low dose of caffeine on 
 antigen-stimulated human lymphocyte activation 
 at rest  
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4.1. Abstract 
This study investigated the effect of a high and low dose of caffeine on 
unstimulated and antigen-stimulated human lymphocyte (CD4+, CD8+ and CD3- 
CD56+) activation  at rest, as assessed by the early activation molecule CD69.  
In a randomised cross-over design, 6 healthy males [age: 25 (2) years; body 
mass: 75 (7) kg, mean ± SD] rested for 3.5 h after ingesting either 0 (PLA), 2 
(2CAF) or 6 (6CAF) mg·kg-1 body mass of caffeine.  Whole blood was 
stimulated with Pediacel (5 in 1) vaccine.  The number of CD3-CD56+ cells were 
significantly higher on 6CAF 1 h and 2.5 h following caffeine ingestion 
compared with both PLA and 2CAF [P<0.05; 1 h, PLA: 0.22 (0.07), 2CAF: 0.21 
(0.07), 6CAF: 0.41 (0.17); 2.5 h, PLA: 0.28 (0.11), 2CAF: 0.20 (0.10), 6CAF: 
0.37 (0.07) x109 cells·L-1].  At these time-points (1 h and 2.5 h) serum caffeine 
concentrations were significantly higher on 6CAF compared with 2CAF and PLA 
and significantly higher on 2CAF compared with PLA [P<0.01; 1 h, PLA: 0 (0), 
2CAF: 16 (8), 6CAF: 48 (11); 2.5 h, PLA: 0 (0), 2CAF: 17 (3), 6CAF: 47 (11) 
µmol·L-1] The number of antigen-stimulated CD3-CD56+ cells expressing CD69 
were also higher on 6CAF 1 h following caffeine ingestion compared with both 
PLA and 2CAF [P<0.05; 1:4000 PLA: 31.16 (18.84), 1:4000 6CAF: 68.02 
(28.54); 1:8000 2CAF: 29.76 (22.69), 1:8000 6CAF: 47.09 (29.34) x106 cells·L-
1].  However, caffeine at a high or low dose had little effect at altering the 
number of T (CD4+ and CD8+) cells exrpressing CD69 in response to antigen 
stimulation.  Similarly, caffeine at a high or low dose had little effect on the 
GMFI expression of CD69 on antigen-stimulated CD4+, CD8+ or CD3- CD56+ 
cells.  It could be suggested that the results of this study may be due to the 
differences between lymphocyte subsets in their density of β2-adrenoreceptors.  
NK cells possess the highest number of β2-adrenoreceptors of all lymphocytes 
and as such may explain why NK cells were the only lymphocyte subset 
responsive to the effects of a large (6 mg·kg-1) dose of caffeine in this study. 
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4.2. Introduction 
Caffeine is a legal and socially acceptable drug and as such is commonly found 
in most people’s diets.  Caffeine’s effects have been determined in a number of 
physiological systems including the cardiovascular, endocrine and central 
nervous systems (reviewed by Benowitz, 1990). However, little research has 
focused on how caffeine may affect various aspects of the immune system 
(reviewed in Horrigan et al., 2006).  Of the research that has been conducted, 
most have used the rodent model and very few studies have used 
concentrations of caffeine considered relevant to “normal” human consumption 
(~70 µM or less; Graham, 2001). Even fewer have used human participants 
(reviewed in Horrigan et al., 2006).   
 
T and NK lymphocytes are critical components of the acquired and innate 
immune system, respectively.  T cells are responsible for orchestrating and 
regulating a highly specific and long lasting cell-mediated or humoral immune 
response to pathogenic invaders (Fabbri et al., 2003), while NK cells play a 
cruical role in defence against viral infection and tumour immune surveillance 
(Andoniou et al., 2006).  At rest (unstimulated), small numbers of peripheral 
blood lymphocytes express low levels of CD69 (Testi et al., 1994; Borrego et 
al., 1999). CD69 is one of the earliest cell surface antigens expressed on 
lymphocytes following activation (Ziegler et al., 1994) and once expressed, is 
believed to trigger subsequent cell proliferation, cytotoxicity and secretion of 
cytokines (Moretta et al., 1991; Borrego et al., 1999; Mueller et al., 2002).   
 
T and NK cells express both β2-adrenoreceptors and adenosine receptors (T 
cells, A2A, A2B and A3; NK cells, A1, A2A and A2B), with the density of these 
receptors increased following activation (Shephard, 2003; Blay and Hoskin, 
2007).  Lymphocytes express a high density of homogenous β2-
adrenoreceptors: CD8+ T cells possess 2-3 times more functional β2-receptors 
than CD4+ T cells, while NK cells possess nearly 50% more β2-receptors than 
CD8+ T cells (Murray et al., 1992).  Both adenosine and adrenaline have been 
shown to inhibit early lymphocyte activation (Shimamiya et al., 2003; Lappas et 
al., 2005), via activation of adenylate cyclase and increased intracellular cAMP 
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(Raskovalova et al., 2006).  At physiological concentrations, caffeine’s main 
mechanism of action has been proposed to be adenosine receptor antagonism, 
with preferential A1 and A2A antagonism (Fredholm et al., 1999).  However, 
caffeine is also known to stimulate the release of adrenaline, which has also 
been shown to affect a number of immune functions (Elenkov et al., 2000; 
Graham, 2001) Therefore, caffeine may have the potential to modulate 
lymphocyte activation either directly via adenosine receptor antagonism or 
indirectly via stimulation of catecholamine release.   
 
To the author’s knowledge no study to date has investigated the effect of 
caffeine on human lymphocyte activation at rest either in vivo/ex vivo or in 
response to stimulation in vitro.  Therefore, the aim of this study was to 
investigate the effect of a high and low dose of caffeine on unstimulated and 
antigen-stimulated lymphocyte (CD4+, CD8+ and CD3-CD56+) activation during 
3.5 h rest, as assessed by expression of CD69.    
 
4.3. Methods 
Participants and trial protocol 
Six healthy participants [mean (SD): age: 25 (2) years; body mass: 75 (7) kg] 
gave written informed consent to take part in the study, which was approved by 
Loughborough University Ethical Advisory Committee.  Daily caffeine intake 
amongst participants was varied and ranged from 30 – 400 mg·day-1.  One 
participant was characterised as a high user (> 250 mg·day-1), 4 as moderate 
users (50 – 250 mg·day-1) and 1 as a light user (< 50 mg·day-1).  Participants 
were randomly assigned to either the PLA, 2CAF or 6CAF trial and acted as 
their own controls in a repeated-measures, single-blind, cross-over design.  
Each trial was separated by 1 week.  Participants arrived at the laboratory at 
08:20 h following an overnight fast.  Participants then ingested 0, 2 or 6 mg·kg-1 
body mass of caffeine and rested quietly in the laboratory for 3.5 h, during 
which time water was consumed ad libitum.  Venous blood samples were 
obtained at pre-supplement (0 h) and 1 h (09:30 h), 2.5 h (11:00 h) and 3.5 h 
(12:00 h) after CAF or PLA ingestion. Laboratory conditions throughout the 
study were 19.5 (0.4) °C and 33.4 (2.9) % relative humidity.   
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Blood analytical methods  
Blood sampling and analysis methods are detailed in Chapter 3.6 
 
Statistical analysis 
Statistical methods are detailed in Chapter 3.7 
 
4.4. Results 
Serum caffeine concentration at 1 h, 2.5 h and 3.5 h after caffeine ingestion was 
higher on 6CAF than 2CAF and PLA and higher on 2CAF than PLA (P<0.01; 
Figure 4.1).   
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Figure 4.1: Serum caffeine concentrations during PLA, 2CAF and 6CAF trials.   
* significantly higher on 6CAF than PLA and 2CAF (P<0.01); ** significantly 
higher on 2CAF than PLA (P<0.01); † significantly higher than pre-supplement 
within trial (P<0.01). Values are means ± SD. 
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At 1 h and 2.5 h after caffeine ingestion, plasma adrenaline concentration was 
significantly higher on 6CAF than PLA (1 h, P<0.01; 2.5 h P<0.05; Figure 4.2).  
There were no differences between 2CAF and PLA.  Caffeine ingestion did not 
affect plasma noradrenaline concentrations (Table 4.1).  Neither caffeine 
ingestion nor time of day affected the number of CD4+ and CD8+ cells within the 
circulating lymphocyte population (Table 4.1).  However, the number of CD3-
CD56+ cells was higher 1 h and 2.5 h after caffeine ingestion on 6CAF than on 
PLA and 2CAF (P<0.05; Figure 4.3).   
 
 
Figure 4.2: Plasma adrenaline concentration during PLA, 2CAF and 6CAF 
trials. Significantly higher on 6CAF than PLA  * P<0.01, ** P<0.05; Significantly 
higher than pre-supplement within trial † P<0.01, †† P<0.05. Values are means + 
SD. 
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Table 4.1: Plasma noradrenaline concentration, total lymphocyte count and 
number of circulating CD4+ and CD8+ cells during PLA, 2CAF and 6CAF trials. 
                                   0 h                            1 h                       2.5 h                       3.5 h  
Plasma noradrenaline concentration (nmol·L-1) a 
PLA 2.01 (0.45) 2.31 (0.47) 2.59 (0.55) - 
2CAF 1.77 (0.30) 2.07 (0.58) 2.29 (0.70) - 
6CAF 1.81 (0.56) 2.27 (0.61) 2.54 (0.69) - 
Total lymphocytes (x109 cells·L-1) 
PLA 1.90 (0.30) 1.70 (0.10) 1.80 (0.20) 1.80 (0.30) 
2CAF 1.80 (0.40) 1.60 (0.40) 1.70 (0.30) 1.80 (0.30) 
6CAF 1.90 (0.30) 2.00 (0.30) 2.00 (0.30) 1.80 (0.10) 
CD4+ cells (x109 cells·L-1) 
PLA 0.77 (0.23) 0.70 (0.11) 0.68 (0.13) 0.67 (0.11) 
2CAF 0.66 (0.19) 0.62 (0.16) 0.62 (0.15) 0.71 (0.14) 
6CAF 0.66 (0.15) 0.62 (0.13) 0.58 (0.19) 0.64 (0.08) 
CD8+ cells (x109 cells·L-1) 
PLA 0.58 (0.10) 0.50 (0.09) 0.51 (0.09) 0.52 (0.13) 
2CAF 0.54 (0.13) 0.50 (0.14) 0.50 (0.11) 0.54 (0.10) 
6CAF 0.50 (0.10) 0.60 (0.25) 0.50 (0.23) 0.49 (0.13) 
Values are mean (SD). 
a Main effect for time: significantly higher than 0 h at 1 h and 2.5 h, P<0.01. 
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Figure 4.3: Number of circulating CD3-CD56+ cells within the lymphocyte 
population during PLA, 2CAF and 6CAF trials. * significantly higher on 6CAF 
than PLA and 2CAF (P<0.05); † significantly higher than pre-supplement within 
trial (P<0.05). Values are means + SD. 
 
There was no effect of caffeine on the number of unstimulated CD4+, CD8+ and 
CD3-CD56+ cells or antigen-stimulated (both doses) CD4+ and CD8+ cells 
expressing CD69 (unstimulated, Table 4.2; antigen-stimulated, Figure 4.4a & b) 
Although, diurnal effects were evident for each of these antigen-stimulated 
(1:8000) measures (main effect for time; P<0.01 for all).  However, a high dose 
of caffeine increased the number of antigen-stimulated CD3-CD56+ cells 
expressing CD69 1 h following caffeine ingestion compared with PLA (1:4000, 
P<0.05; Figure 4.4c) and a low dose of caffeine (1:8000, P<0.05; Figure 4.4c).  
Neither caffeine ingestion nor time of day affected the GMFI of CD69 
expression on unstimulated (Table 4.2) or antigen-stimulated (both optimal and 
suboptimal doses) CD4+, CD8+ and CD3- CD56+ cells (Figure 4.5a, b & c).   
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Table 4.2: Number of circulating unstimulated CD4+, CD8+ and CD3-CD56+ 
cells expressing CD69 and the GMFI expression of CD69 during PLA, 2CAF 
and 6CAF trials. 
      0 h                          1 h                          2.5 h                       3.5 h  
CD4+ CD69+ cells (x106 cells·L-1) 
PLA 5.7 (3.0) 6.1 (2.4) 6.8 (4.3) 11.7 (3.7)  
2CAF 9.6 (6.1) 8.9 (6.0) 12.2 (7.0) 13.3 (12.7) 
6CAF 13.8 (6.6) 15.9 (8.4) 11.7 (8.6) 13.8 (8.1)  
CD8+ CD69+ cells (x106 cells·L-1) 
PLA 20.2 (12.7) 19.2 (15.0) 19.4 (11.2) 28.1 (18.3) 
2CAF 13.6 (12.2) 13.7 (11.0) 15.5 (13.1) 16.5 (10.0) 
6CAF 19.2 (12.8) 23.6 (16.3) 20.0 (13.6) 18.5 (11.5) 
CD3-CD56+ CD69+ cells (x106 cells·L-1) 
PLA 27.3 (27.4) 16.7 (13.5) 24.0 (19.0) 35.4 (27.2) 
2CAF 25.6 (25.9) 28.5 (31.8) 28.7 (36.1) 30.2 (34.9) 
6CAF 54.3 (53.5) 23.6 (45.4) 55.2 (45.2) 33.8 (24.7) 
CD4+ CD69+ GMFI 
PLA 100 (0) 99 (13) 91 (23) 100 (19) 
2CAF 100 (0) 123 (68) 99 (32) 112 (31) 
6CAF 100 (0) 90 (16) 98 (18) 80 (18) 
CD8+ CD69+ GMFI 
PLA 100 (0) 100 (32) 106 (26) 95 (23) 
2CAF 100 (0) 113 (33) 103 (25) 104 (24) 
6CAF 100 (0) 100 (24) 104 (31) 108 (15) 
CD3-CD56+ CD69+ GMFI 
PLA 100 (0) 97 (11) 103 (17) 100 (17) 
2CAF 100 (0) 115 (30) 104 (22) 111 (28) 
6CAF 100 (0) 100 (11) 112 (30) 109 (23) 
Values are mean (SD).  The GMFI expressions are expressed as a percentage relative to pre-
supplement value. 
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Figure 4.4: Number of antigen-stimulated (a) CD4+ T cells, (b) CD8+ T cells and    
(c) CD3-CD56+ NK cells expressing CD69 within the circulating lymphocyte 
population during PLA, 2CAF and 6CAF trials.  * significantly higher on 6CAF 
than PLA (P<0.05); ** significantly higher on 6CAF than 2CAF (P<0.05);            
†
 significantly higher than pre-supplement within trial (P<0.05). Values are 
means + SD. 
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Figure 4.5: Geometric Mean Fluorescence Intensity of CD69 expression on 
antigen-stimulated (a) CD4+ T cells, (b) CD8+ T cells and (c) CD3-CD56+ NK 
cells within the circulating lymphocyte population during PLA, 2CAF and 6CAF 
trials. Values are means + SD and are expressed as a percentage relative to 0 
h (pre-supplement) value.  
 
4.5. Discussion 
The main findings of this study suggest that (i) ingesting a high (6 mg·kg-1), but 
not a low (2 mg·kg-1) dose of caffeine mobilises CD3-CD56+ cells into the 
peripheral circulation 1 h and 2.5 h following caffeine ingestion, when compared 
with placebo, (ii) a high dose of caffeine also increases the number of antigen-
stimulated CD3-CD56+ cells expressing CD69 1 h following caffeine ingestion 
compared with both placebo and a low dose of caffeine, (iii) ingesting high and 
low doses of caffeine has little influence on antigen-stimulated T (CD4+ and 
CD8+) cell activation, as assessed by the number of cells expressing CD69 or 
on antigen-stimulated T (CD4+ and CD8+) and NK (CD3-CD56+) cell activation 
on a per cell basis, as assessed by the GMFI expression of CD69. 
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The increased number of NK cells within the circulation 1 h and 2.5 h after 
ingesting 6 mg·kg-1 caffeine (but not after ingesting 2 mg·kg-1 caffeine or 
placebo) may be associated with the increase in plasma adrenaline 
concentration seen at these time-points. Adrenaline is known to alter adhesion 
molecules on lymphocytes via stimulation of their β2-adrenorecptors, leading to 
an increase in intracellular cAMP (Shephard, 2003), which in turn is thought to 
be responsible for interfering with signals necessary for adhesion strengthening 
(Benschop et al., 1997).  Lymphocytes express a high density of homogenous 
β2-adrenoreceptors: CD8+ T cells possess 2-3 times more functional β2-
receptors than CD4+ T cells, while NK cells possess nearly 50% more β2-
receptors than CD8+ T cells (Murray et al., 1992).  This may explain why in the 
present study only NK cells appeared to be responsive to the effects of a high 
dose of caffeine.  Furthermore, only a high dose of caffeine appeared to 
increase the number of activated NK cells in response to antigen stimulation 
compared with placebo or the lower dose of caffeine.  Therefore, it may be that 
increases in plasma adrenaline concentration could have led to a preferential 
mobilisation of a specific population of NK cells with an increased propensity for 
activation when stimulated into the peripheral circulation.  
 
In the present study both high and low doses of caffeine had little effect on 
antigen-stimulated T and NK cell activation on a per cell basis (as assessed by 
the GMFI expression of CD69).  This is in contrast to several reports that 
caffeine at physiological concentrations decreases mitogen/antigen stimulated 
lymphocyte proliferation, antibody production and cytokine production 
(Kantamala et al., 1990; Rosenthal et al., 1992).  However, these studies used 
rodent models to investigate the possible effects of caffeine.  This in itself raises 
issues when trying to compare these results to those from human studies as 
caffeine metabolism and plasma half-life (plasma half life in rodents: 0.7-1.2 h 
vs. humans: 4-6 h) between rodents and humans differs significantly (Fredholm 
et al., 1999).  The major metabolic difference between species is that in the rat 
more than 40% of caffeine metabolites are trimethyl derivatives as compared 
with less than 6% in humans (Arnaud, 1985). 
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At physiological concentrations, it is thought that caffeine’s main mechanism of 
action is via adenosine receptor antagonism (Fredholm et al., 1999).   However, 
under physiological conditions, caffeine will only actively compete as an 
adenosine receptor antagonist when the receptors are engaged by endogenous 
adenosine (Yang et al., 2009).  As such, it could be suggested that in the 
present study caffeine (regardless of dose) had little effect on antigen-
stimulated lymphocyte activation (GMFI expression of CD69) in resting 
participants due to plasma adenosine concentrations being too low to engage 
caffeine as an adenosine receptor antagonist.  It should be noted that plasma 
adenosine concentration was not measured in this study and as such this 
explanation is only speculation.  However, support for this speculation comes 
from the exercise literature where prolonged intensive exercise, which is known 
to markedly increase plasma adenosine concentrations (Vizi et al., 2002), 
increased the number of unstimulated CD4+ and CD8+ T cells expressing CD69 
(Bishop et al., 2005a).  
 
In summary, this is the first study in humans to determine that a high 6 mg·kg-1 
(but not a low 2 mg·kg-1) dose of caffeine is associated with the mobilisation of 
CD3-CD56+ cells into the peripheral circulation 1h and 2.5 h following ingestion, 
and that in response to antigen stimulation a higher number of these mobilised 
cells express the early activation marker, CD69.  In contrast, caffeine ingestion 
(regardless of dose) has little effect on T cell trafficking or on antigen-stimulated 
T and NK cell activation on a per cell basis in humans.  Therefore, these 
findings indicate that caffeine ingestion does not appear to compromise host 
responses to antigenic challenge and in fact a high dose of caffeine may even 
be protective 1 h following caffeine ingestion.  These findings are in contrast to 
previously published studies in the animal model and as such suggest that 
perhaps using animals to investigate the effects of caffeine on human immune 
functions may not be a reliable model.   
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       Caffeine ingestion and antigen-stimulated 
 human lymphocyte activation after prolonged 
 cycling   
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5.1. Abstract  
This study investigated the effect of caffeine ingestion on antigen-stimulated T 
(CD4+ and CD8+) and natural killer (CD3-CD56+) cell activation after prolonged, 
strenuous cycling.  In a randomised cross-over design, 9 male endurance 
cyclists [age: 22 (3) years, peakOV 2& : 62 (4) ml·kg-1·min-1, mean ± SD] cycled for 
90 min at 70% peakOV 2&  60 min after ingesting 6 mg·kg-1 body mass of caffeine 
(CAF) or placebo (PLA).  Venous blood samples were obtained before 
supplementation, pre-exercise, immediately post-exercise and 1 h post-
exercise.  Whole blood was stimulated with Pediacel (5 in 1) vaccine.  At 1 h 
post-exercise the number of antigen-stimulated CD4+ cells expressing CD69 
decreased on CAF compared with PLA [15 (17) x106 cells·L-1 vs. 23 (22) x106 
cells·L-1, P<0.05]. In addition, the GMFI of CD69 expression on antigen-
stimulated CD8+ cells decreased on CAF compared with PLA 1 h post-exercise 
[78 (10)% vs. 102 (24)%, P<0.05]. At the same time-point GMFI of CD69 
expression on antigen-stimulated CD3-CD56+ cells was increased on CAF 
compared with PLA [103 (9)% vs. 87 (8)%, P<0.05]. These findings suggest 
that caffeine reduces antigen-stimulated CD69 expression on T cells while at 
the same time increases NK cell activation 1 h after intensive cycling. 
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5.2. Introduction 
Caffeine is a common element in most athletes’ diets, yet it is not a typical 
nutrient nor is it essential for health (Chester and Wojek, 2008).  Many athletes 
consume caffeine for its known ergogenic properties, which have been 
extensively documented (Goldstein et al., 2010).  Since being legitimised by its 
2004 removal from the WADA prohibited list of substances, caffeine’s ability to 
enhance athletic performance during training and/or competition has led to its 
widespread use amongst this population, with use by cyclists particularly 
common (Chester and Wojek, 2008). 
 
Caffeine is a non-selective adenosine receptor antagonist and stimulates 
adrenaline release from the adrenal medulla.  Increased concentrations of 
adenosine and adrenaline have been shown to inhibit T and NK cell function in 
vitro and in vivo (Kappel et al., 1991; Murray et al., 1992; Huang et al., 1997), 
via activation of adenylate cyclase and increased intracellular cAMP (Grader-
Beck et al., 2003; Raskovalova et al., 2006).  Strenuous exercise increases the 
plasma concentrations of both adenosine and adrenaline (Hartley et al., 1972; 
Vizi et al., 2002) and adrenaline in particular has been suggested to be an 
important influence on the temporary perturbations in circulating T and NK cell 
numbers and functions observed following intensive exercise (Hoffman-Goetz 
and Pedersen, 1994).  These perturbations are thought to partly account for the 
apparent higher incidence of viral respiratory infection experienced by some 
elite athletes (Gleeson, 2007).  It follows, therefore, that ingesting caffeine 
before strenuous exercise may exacerbate the exercise-associated cellular 
influences of adenosine and adrenaline and in this way influence subsequent T 
and NK cell functions. 
 
Despite the reported widespread use of caffeine by many athletes to enhance 
performance, few published studies have investigated caffeine’s effects on 
various aspects of the immune system after high intensity exercise (Bishop et 
al., 2005a, 2006b; Walker et al., 2006, 2007, 2008). Bishop et al. (2005a) have 
previously demonstrated an increase in numbers of circulating CD4+ and CD8+ 
cells expressing CD69 1 h after consuming 6 mg·kg-1 body mass caffeine and 
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also immediately after cycling for 90 min at 70% peakOV 2& , compared with 
placebo.  However, these findings may simply reflect an adrenaline-mediated 
redistribution of cells and do not provide information regarding the effect of 
caffeine on T cell activation to an antigenic challenge.  Furthermore, to the 
author’s knowledge no study to date has investigated the effect of caffeine on 
any aspect of antigen-stimulated NK cell number or function following a bout of 
intensive exercise. Taking this information together with caffeine’s widespread 
use amongst the athletic population emphasises a need to understand the 
effect that caffeine may have on an athlete’s immune system and subsequent 
risk of infection following high intensity exercise. Therefore, the aim of this study 
was to investigate the effects of prior caffeine ingestion on antigen-stimulated T 
(CD4+ and CD8+) and NK (CD3-CD56+) cell activation following 90 min cycling 
at 70% peakOV 2& , as assessed by expression of the early activation marker CD69.   
 
5.3. Methods 
Participants 
Nine endurance trained male cyclists [age 22 (3) years; body mass 75 (4) kg; 
peakOV 2&  62 (4) ml·kg-1·min-1; peak power output 354 (39) W] volunteered to 
participate in this study.  All participants were fully informed about the rationale 
for the study and the design of the exercise tests and trial protocol, along with 
their possible risks and discomforts, before providing written informed consent.  
Loughborough University Ethical Advisory Committee approved the study.  
Daily caffeine intake amongst participants was varied and ranged from 30 – 506 
mg·day-1.  Two participants were characterised as high users (> 250 mg·day-1), 
4 as moderate users (50 – 250 mg·day-1) and 3 as light users (< 50 mg·day-1).   
 
Experimental procedures 
Approximately 2 weeks before the beginning of the main trials, each participant 
was required to undertake preliminary measurements including a peakOV 2&  test 
and a familiarisation of the trial protocol.  Preliminary measurements and pre-
trial standardisation procedures are described in Chapter 3.  Participants 
performed 2 main exercise trials separated by 1 week.  Participants were 
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randomly assigned to either the caffeine (CAF) or placebo (PLA) trial and acted 
as their own controls in a repeated-measures, single-blind, cross-over design.  
Participants arrived at the laboratory at 08:20 h following an overnight fast. 
Participants then ingested 6 mg·kg-1 body mass of either CAF or PLA and 
rested quietly in the laboratory for 1 h.  Immediately after this, participants 
began cycling at a work rate equivalent to 70% peakOV 2&  [235 (29) W].  Venous 
blood samples were obtained at pre-supplement, 1 h after CAF or PLA 
ingestion (pre-exercise), immediately post-exercise and 1 h post-exercise.  
Laboratory conditions throughout the study were 20.5 (1.3) °C and 40.9 (4.5) % 
relative humidity. 
 
Blood analytical methods  
Blood sampling and analysis methods are detailed in Chapter 3.6 
 
Statistical analysis 
Statistical methods are detailed in Chapter 3.7 
 
5.4. Results 
Exercise intensity, heart rate and indirect calorimetry   
Mean exercise intensity did not differ between trials [CAF: 72.8% (3.1) PLA: 
72.5% (2.9)].  Heart rates were comparable between trials during exercise 
[CAF: 161 (9) beat·min-1, PLA: 156 (11) beat·min-1; mean of all recordings].  
Respiratory exchange ratio (RER) and fat and CHO oxidation rates were similar 
between trials throughout exercise [CAF: 0.95 (0.01), 0.40 (0.20) g·min-1, 3.10 
(0.60) g·min-1, PLA: 0.95 (0.01), 0.40 (0.30) g·min-1, 3.00 (0.80) g·min-1, for 
RER, fat and CHO oxidation rates, respectively].  Likewise, energy expenditure 
(EE) and the percentage contribution of fat and CHO did not differ between 
trials [EE: 67 (6) KJ·min-1 for both CAF and PLA, contribution of fat: 20.6 (14.1) 
% and 25.3 (15.1) %, contribution of CHO: 79.4 (14.1) % and 74.7 (15.1) % on 
CAF and PLA, respectively]. 
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Changes in body mass and plasma volume 
After exercise, change in body mass (corrected for fluid intake) was similar for 
both trials [CAF: -1.7 (0.3) kg, PLA: -1.6 (0.3) kg].  There was no significant time 
x trial interaction effect for changes in plasma volume relative to the initial blood 
sample.  After exercise plasma volume decreased by 9.5 (3.1)% and 9.9 (6.2)% 
on the CAF and PLA trials, respectively. 
 
Serum caffeine and plasma catecholamines 
A significant time x trial interaction was found for serum caffeine concentration 
(P<0.01), with higher concentrations at pre, post and 1 h post-exercise on CAF 
compared with PLA (P<0.01; Table 5.1).  A significant time x trial interaction 
was found for plasma adrenaline concentration, with values significantly higher 
on CAF than PLA post-exercise (P<0.05; Table 5.1).  A significant main effect of 
time was found for plasma noradrenaline concentration, with values elevated 
above pre-supplement levels at post-exercise (P<0.01; Table 5.1).  
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Table 5.1: Serum caffeine, plasma adrenaline, noradrenaline concentrations, 
total lymphocyte count and number of circulating CD4+, CD8+ and CD3-CD56+ 
cells during CAF and PLA trials. 
                        Pre-supplement      Pre-exercise      Post-exercise            1 h post-exercise 
Serum caffeine concentration (µmol·L-1) 
CAF                             0 (0)          52 (15) * † 60 (17) * †                   48 (12) * †    
PLA                             0 (0)                      0 (0)                     0 (0)                          0 (0) 
Plasma adrenaline concentration (nmol·L-1) 
CAF                         0.32 (0.23)         0.42 (0.24)       1.49 (0.69) ** ††             - 
PLA                         0.30 (0.18)        0.24 (0.15)        0.69 (0.25) ††                 -       
Plasma noradrenaline concentration (nmol·L-1) c 
CAF                         1.97 (0.91)          2.31 (1.28)         8.45 (2.89)                     - 
PLA                         2.28 (1.02)         2.40 (0.87)       6.76 (1.58)                     -         
Total lymphocytes (x109 cells·L-1) a,b,d 
CAF                         2.00 (0.60)     1.80 (0.40)         2.50 (1.30)                   1.30 (0.50) 
PLA                         2.00 (0.70)           1.70 (0.50)       2.30 (0.80)                   1.40 (0.40) 
CD4+ cells (x109 cells·L-1) a,d 
CAF                         0.68 (0.26)  0.57 (0.20) 0.65 (0.39) 0.45 (0.18) 
PLA                         0.72 (0.35) 0.57 (0.21)        0.62 (0.27) 0.49 (0.17) 
CD8+ cells (x109 cells·L-1) c,d 
CAF                         0.59 (0.27) 0.56 (0.25) 0.93 (0.66) 0.37 (0.19) 
PLA                         0.61 (0.31) 0.51 (0.28) 0.80 (0.41) 0.40 (0.18) 
CD3-CD56+ cells (x109 cells·L-1)    
CAF  0.34 (0.16) 0.38 (0.16) ** 0.63 (0.43) ** † 0.27 (0.17) †† 
PLA                 0.36 (0.26) 0.29 (0.19) 0.53 (0.35) †† 0.20 (0.14) † 
Values are mean (SD). n = 7 for adrenaline and noradrenaline.  
* P<0.01, ** P<0.05: significantly higher on CAF than PLA.  
† P<0.01, †† P<0.05: significantly different than pre-supplement within trial. 
Main effect for time: significantly lower than pre-supplement at pre-exercise, a P<0.01. 
Main effect for time: significantly different than pre-supplement at post-exercise, 
b
 P<0.05, c P<0.01. 
Main effect for time: significantly lower than pre-supplement at 1 h post-exercise, d P<0.01, e 
P<0.05. 
 
Circulating lymphocyte counts and numbers of CD4+, CD8+ and CD3-CD56+ 
cells 
No significant time x trial interaction was found for number of circulating 
lymphocytes but there was a significant main effect for time (P<0.01) with the 
circulating number of lymphocytes following a biphasic response to exercise 
(Table 5.1).  A significant time x trial interaction was found for the number of 
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CD3-CD56+ cells within the circulating lymphocyte population, with values 
higher at pre-exercise and post-exercise on CAF compared with PLA (P<0.05; 
Table 5.1).  Although there were no significant time x trial interactions for the 
number of CD4+ or CD8+ cells within the circulating lymphocyte population, 
there was a significant main effect for time (both P<0.01; Table 5.1). The 
number of CD4+ cells decreased at pre-exercise and 1 h post-exercise when 
compared to pre-supplement numbers (P<0.01), while CD8+ cells increased at 
post-exercise, only to fall significantly below pre-supplement values 1 h later 
(P<0.01).   
 
Number of unstimulated and antigen-stimulated CD4+, CD8+ and CD3-CD56+ 
cells expressing CD69  
There were no time x trial interaction effects for the number of unstimulated 
CD4+, CD8+ or CD3-CD56+ cells expressing CD69.  However, the number of 
unstimulated CD4+ cells expressing CD69 increased significantly above pre-
supplement values at immediately post-exercise, while the number of CD3-
CD56+ cells expressing CD69 decreased below pre-supplement values at 1 h 
post-exercise (main effect for time only; P<0.01; Table 5.2). When cells were 
stimulated, a significant time x trial interaction was found for the number of 
antigen-stimulated (1:4000) CD4+ cells expressing CD69, with values 
significantly lower on CAF than PLA at 1 h post-exercise (P<0.05; Table 5.2).  
There were no significant time x trial interaction effects for the number of 
antigen-stimulated (1:4000 or 1:8000) CD8+ or CD3-CD56+ cells expressing 
CD69 (Table 5.2), although the number of antigen-stimulated (both doses) CD3-
CD56+ cells did appear to fall significantly below pre-supplement values 1 h 
following exercise (main effect for time only; both P<0.01; Table 5.2).   
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Table 5.2:  Number of unstimulated and antigen-stimulated CD4+, CD8+ and 
CD3-CD56+ cells expressing CD69 during CAF and PLA trials. 
                       Pre-supplement      Pre-exercise        Post-exercise      1 h post-exercise 
CD4+ CD69+ cells (x106 cells·L-1) a  
unstim CAF 11.8 (14.5)  7.7 (8.0) 13.5 (15.0) 6.8 (7.1) 
unstim PLA 14.0 (20.1) 12.5 (16.0) 17.3 (17.1) 10.1 (7.4) 
1:4000 CAF  35.6 (29.5) 32.0 (20.9) 32.4 (28.0) 15.4 (16.5) * † 
1:4000 PLA 40.3 (36.9) 29.5 (21.0) 22.4 (13.2) 23.5 (22.3)  
1:8000 CAF  28.7 (22.3) 26.8 (22.8) 31.9 (33.2) 13.1 (14.0) 
1:8000 PLA 33.7 (32.2) 27.4 (20.7) 23.1 (15.9)              16.9 (16.4)  
CD8+ CD69+ cells (x106 cells·L-1) 
unstim CAF 47.4 (21.3) 52.0 (23.2) 91.8 (69.4) 27.2 (8.7) 
unstim PLA  63.7 (60.0) 58.9 (53.9) 91.7 (70.4) 42.4 (39.4) 
 1:4000 CAF  68.8 (59.7) 75.7 (64.7)  101.2 (65.0) 30.8 (12.3) 
1:4000 PLA 87.0 (79.2) 76.6 (67.6) 102.1 (83.5) 51.2 (46.6) 
1:8000 CAF  62.5 (48.3) 82.8 (54.7) 115.8 (69.1) 37.1 (21.3) 
1:8000 PLA 90.5 (80.6) 70.8 (72.6) 98.9 (89.2) 44.3 (49.4) 
CD3-CD56+ CD69+ cells (x106 cells·L-1) b 
unstim CAF 38.5 (46.1) 21.4 (15.0) 45.5 (57.1) 13.1 (15.1) 
unstim PLA  35.9 (30.2) 27.7 (26.6) 38.0 (38.4) 14.7 (17.3) 
1:4000 CAF  54.8 (56.2) 61.4 (58.1) 81.9 (28.0) 28.0 (24.2) 
1:4000 PLA 75.4 (81.2) 41.0 (27.4) 60.4 (39.4) 30.6 (28.7)   
1:8000 CAF  60.0 (53.6) 67.0 (58.6) 61.5 (46.6) 25.0 (26.8) 
1:8000 PLA  63.8 (71.1) 45.7 (37.0) 53.6 (47.9) 20.9 (17.7) 
Values are mean (SD). 
* P<0.05, significantly lower on CAF than PLA.  
†
 P<0.01: significantly different from pre-supplement within trial. 
a  Main effect for time on unstim cells: significantly higher than pre-supplement at post-exercise, 
P<0.01. 
b  Main effect for time: significantly lower than pre-supplement at 1 h post-exercise, P<0.01. 
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Geometric Mean Fluorescence Intensity of CD69 expression on unstimulated 
and antigen-stimulated CD4+, CD8+ and CD3-CD56+ cells 
There were no time x trial interaction or main effects for GMFI of CD69 
expression on unstimulated CD4+, CD8+ or CD3-CD56+ cells (Table 5.3).  When 
cells were stimulated, GMFI of CD69 expression on antigen-stimulated (1:8000) 
CD4+ T cells approached significance (P for interaction=0.054; Figure 5.1a), 
while both antigen-stimulated (1:8000) CD8+ and CD3-CD56+ cells showed a 
significant time x trial interaction (both P<0.05; Figure 5.1b & c).  The GMFI of 
CD69 expression on antigen-stimulated (1:8000) CD8+ cells was significantly 
lower on CAF compared to PLA at 1 h post-exercise (P<0.05; Figure 5.1b); for 
the same time-point the GMFI of CD69 expression on antigen-stimulated 
(1:8000) CD3-CD56+ cells was significantly higher on CAF compared to PLA 
(P<0.05; Figure 5.1c).   
 
Table 5.3: Relative GMFI of CD69 expression on unstimulated CD4+, CD8+ and 
CD3-CD56+ cells during CAF and PLA trials. 
             Pre-supplement        Pre-exercise            Post-exercise                1 h post-exercise 
CD4+ CD69+ GMFI 
CAF  100 (0) 109 (39) 105 (28) 101 (29) 
PLA  100 (0) 99 (10) 99 (24) 97 (20) 
CD8+ CD69+ GMFI 
CAF  100 (0) 110 (20) 111 (15) 109 (22) 
PLA  100 (0) 95 (12) 95 (10) 99 (10) 
CD3-CD56+ CD69+ GMFI 
CAF  100 (0) 100 (11) 103 (17) 105 (13) 
PLA  100 (0) 96 (16) 95 (13) 91 (14) 
Values are mean (SD).  GMFI expression of CD69 is expressed as a percentage relative to pre-
supplement values. 
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Figure 5.1:  Geometric Mean Fluorescence Intensity of CD69 expression on 
antigen-stimulated (a) CD4+ T cells, (b) CD8+ T cells and (c) CD3- CD56+ NK 
cells within the circulating lymphocyte population during CAF and PLA trials.       
* significantly lower on CAF than PLA (P<0.05);  ** significantly higher on CAF 
than PLA (P<0.05); significantly lower than pre-supplement within trial             
(†† P<0.01; † P<0.05).  Values are means + SD and are expressed as a 
percentage relative to pre-supplement value.  
 
5.5. Discussion 
The present study found that ingesting 6 mg·kg-1 body mass caffeine 1 hour 
before performing prolonged, intensive exercise was associated with (i) a 
reduction in the number of antigen-stimulated CD4+ cells expressing CD69, (ii) 
a lowering of the intensity of CD69 expression on antigen-stimulated CD8+ cells 
and (iii) an increase in the intensity of CD69 expression on antigen-stimulated 
CD3-CD56+ cells 1 h after exercise compared with placebo.  Furthermore, 
caffeine (compared with placebo) ingestion was also associated with greater 
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elevations in plasma adrenaline and serum caffeine concentrations.  This 
suggests that ingesting caffeine at a dose of 6 mg·kg-1 body mass (compared 
with placebo) 1 h prior to exercise simultaneously reduced T cell activation and 
increased NK cell activation, 1 hour after 90 min cycle exercise at 70% peakOV 2& .   
 
The present study demonstrates the complex effects of caffeine on peripheral 
lymphocytes 1 h following 90 min cycle exercise at 70% peakOV 2& .  As caffeine 
can act via the same pathways for T and NK cells, it might have been expected 
that for the same dose of caffeine both cell types would have responded 
similarly; this was not the case.  This apparent immunosuppressive (T cells) and 
immunostimulatory (NK cells) effect of caffeine on lymphocyte activation may be 
explained through its ability to alter intracellular cAMP concentration.  T and NK 
cell function have been shown to be inhibited through the actions of adenosine 
and adrenaline via adenosine and β2-adrenergic receptors, respectively (Kappel 
et al., 1991; Huang et al., 1997), via activation of adenylate cyclase and 
increased intracellular cAMP (Grader-Beck et al., 2003; Raskovalova et al., 
2006).  Therefore, caffeine may have acted to increase intracellular levels of 
cAMP in T cells via increased plasma levels of adrenaline, subsequently 
stimulating T cell β2-adrenergic receptors, increasing intracellular cAMP 
(Grader-Beck et al., 2003), thereby reducing cellular activation.  Given the 
amplified adrenaline response on the CAF trial at post-exercise, it seems 
plausible that the decrease of antigen-stimulated T cell activation reported here 
with caffeine ingestion at 1 h post-exercise reflects a caffeine-influenced 
adrenaline-mediated decrease of T cell activation.  
 
While the effects of adrenaline may help to explain the reduction in antigen-
stimulated T cell activation, it can not easily explain the apparent stimulatory 
effect of caffeine ingestion on NK cell activation 1 h following high intensity 
exercise.  Here, it seems more likely that the overriding influence of caffeine is 
via adenosine receptor antagonism.  In this way, caffeine may act to impede the 
adenosine-mediated increase in intracellular levels of cAMP via antagonism of 
NK cell A2A adenosine receptors (Raskovalova et al., 2006).  It is worth noting 
that NK cells also possess A1 adenosine receptors, however blockade of this 
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subclass leads to increases in cAMP and suppressed NK cell functions and 
therefore is unlikely to play a principal role here.  Although plasma adenosine 
concentration was not measured in this study it is reported that caffeine doses 
that approximate to that used in this study increased levels of adenosine by 
adenosine receptor blockade in the rat model (Conlay et al., 1997).  It should be 
noted that the mechanisms discussed here are unlikely to be exclusive; the 
observable effect of caffeine ingestion on T and NK cell responses to antigenic 
challenge most likely reflects the net result of both stimulatory and inhibitory 
influences.  The findings of the present study suggest that enhanced adrenergic 
stimulation of T cells and A2A adenosine receptor antagonism of NK cells are 
the foremost pathways by which caffeine at a dose of 6 mg·kg-1 is acting here. 
 
It could be suggested that the increase in NK cell activation observed 1 h 
following high intensity exercise was an attempt by the innate arm of the 
immune system to compensate for the reduction in T cell activation seen within 
the acquired arm of the immune system.  In support of this notion, other studies 
using a similar protocol to that of the current study found caffeine to transiently 
enhance measures of mucosal immune function [salivary immunoglobulin A (s-
IgA)] during exercise (Bishop et al., 2006b), and attenuate the post-exercise fall 
in formyl-methionyl-leucyl-phenylalanine stimulated neutrophil oxidative burst 
responses (Walker et al., 2006, 2007).  Both s-IgA and neutrophils are aspects 
of the innate immune system that along with NK cells represent a major first line 
of defence against infectious agents.  This highlights the limitation of focussing 
on specific cellular responses and extrapolating these findings to any potential 
outcome for overall host immunity and infection risk.  Future work should 
involve using in vivo cell-mediated immune function tests to determine the effect 
of caffeine ingestion on whole body cell-mediated responses following high 
intensity exercise. 
  
Studies (both in vitro and in vivo) that have investigated dose-response effects 
of caffeine on human and rat lymphocyte functions have shown that different 
doses of caffeine exert different affects over lymphocyte function (Kantamala et 
al., 1990; Rosenthal et al., 1992).  This could help to explain why a 6 mg·kg-1 
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dose of caffeine in this study was beneficial for NK cell function but unbeneficial 
for T cell function 1 h after intensive exercise.  Although a 6 mg·kg-1 (~450 g in 
this study) dose of caffeine has been consistently shown to be ergogenic 
(Goldstein et al., 2010), athletes tend to ingest much smaller amounts of 
caffeine (~2-3 mg·kg-1 or ~200 mg) to enhance athletic performance (Chester 
and Wojek, 2008).   Therefore, investigating a smaller and possibly more 
realistic dose of caffeine on lymphocyte function following high intensity 
exercise will be investigated in Chapter 6.   
 
In summary, the findings of the present study suggest that ingesting 6 mg·kg-1 
body mass caffeine 1 h before prolonged intensive exercise reduces the 
antigen-stimulated expression of CD69 on CD4+ and CD8+ T cells, while 
simultaneously increasing antigen-stimulated CD3-CD56+ NK cell activation 1 h 
post-exercise.   These findings are not apparent when caffeine is ingested 
without subsequent exercise (Chapter 4).  It is suggested that enhanced 
adrenergic stimulation and A2A adenosine receptor antagonism are the main 
pathways by which caffeine reduces and increases T and NK cell activation, 
respectively.  Despite caffeine’s immunomodulatory influence on T and NK cell 
activation the clinical significance of this in terms of subsequent infection risk is 
yet to be determined. 
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 Chapter 6 
 
 
 
 
 
 
       Effect of a high and low dose of caffeine on 
 antigen-stimulated human natural killer cell 
 activation after prolonged cycling   
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6.1. Abstract  
In Chapter 5 a high dose of caffeine ingested 1 h prior to exercise increased 
antigen-stimulated NK cell activation 1 h following 90 min cycling at 70% 
peakOV 2& .  However, it was suggested that perhaps different doses of caffeine 
exert differential effects upon lymphocyte activation in response to prolonged 
exercise. As such this study investigated the effect of a high and low dose of 
caffeine on antigen-stimulated natural killer (CD3-CD56+) cell activation after 
prolonged, strenuous cycling, as assessed by the early activation molecule 
CD69.  In a randomised cross-over design, 12 healthy male endurance trained 
cyclists [age: 22 (2) years, peakOV 2& : 61 (4) ml·kg-1·min-1, mean ± SD] cycled for 
90 min at 70% peakOV 2&  60 min after ingesting either 0 (PLA), 2 (2CAF) or 6 
(6CAF) mg·kg-1 body mass of caffeine.  Whole blood was stimulated with 
Pediacel (5 in 1) vaccine. A high dose of caffeine increased the number of CD3-
CD56+ cells into the circulation at immediately post-exercise compared with 
PLA [P<0.05; PLA: 0.62 (0.30) x109 cells·L-1 vs. 6CAF: 0.79 (0.36) x109 cells·L-
1].  For both 2CAF and 6CAF, the GMFI of CD69 expression on unstimulated 
CD3-CD56+ cells was significantly higher compared with PLA at 1 h post-
exercise [both P<0.05; PLA: 93 (13)%, 2CAF: 110 (12)%, 6CAF: 123 (33)%].  
When cells were stimulated with antigen, the GMFI of CD69 expression 
remained significantly higher on 2CAF than on PLA at 1 h post-exercise 
[P<0.05; 1:8000 PLA: 98 (9)% vs. 1:8000 2CAF: 122 (32)%].  Although not 
achieving statistical significance, 6CAF also followed a similar trend when 
stimulated (P=0.09).  These results suggest that caffeine at a high (6 mg·kg-1) 
dose is associated with recruitment of NK cells into the circulation and that both 
a high and low (2 mg·kg-1) dose of caffeine increases unstimulated and antigen-
stimulated natural killer cell activation 1 h following high intensity exercise.  As 
such there does not appear to be a dose-dependent effect of caffeine on natural 
killer cell activation 1 h following prolonged intensive cycling. 
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6.2. Introduction 
It has been well documented that caffeine between the doses of 3 and 6 mg·kg-
1
 body mass enhances athletic performance (Graham, 2001), however, doses 
as low as 2 mg·kg-1 body mass (~150-200 mg) have also proved ergogenic 
(Cox et al., 2002).   
 
Many athletes do not consume large amounts of caffeine (~450 mg) in one 
bolus dose, instead they tend to ingest much smaller amounts (~200 mg) to 
enhance performance (Chester and Wojek, 2008). A study by Kantamala et al. 
(1990) demonstrated that different doses of caffeine exert differential influences 
over NK cell cytotoxic activity in rats at rest. Caffeine doses between 5 and 40 
µg·ml-1 had little effect on NK cell cytotoxicity in vitro.  However a 6 mg·kg-1·day-
1
 dose of caffeine ingested consecutively for 120 days in vivo significantly 
decreased NK cell function, while both 2 and 18 mg·kg-1·day-1 caffeine doses 
had no effect.  To the author’s knowledge no study to date has investigated the 
effect of different doses of caffeine on human NK cell function following a bout 
of high intensity exercise.  However, data described in Chapter 5 demonstrate 
that ingesting 6 mg·kg-1 body mass caffeine 1 h prior to 90 min cycling at 70% 
peakOV 2&  increases NK cell activation 1 h post-exercise compared with PLA.   
Therefore, the aim of this study was to determine the effect of a high and low 
dose of caffeine on NK cell activation, following 90 min cycling at 70% peakOV 2& , 
as assessed by the early activation marker CD69.   
 
6.3. Methods 
Participants 
Twelve endurance trained male cyclists [age: 22 (2) years; body mass: 71 (6) 
kg; peakOV 2&  61 (4) ml·kg-1·min-1; peak power output: 330 (25) W] volunteered to 
participate in this study.  All participants were fully informed about the rationale 
for the study, along with their possible risks and discomforts, before providing 
written informed consent.  Loughborough University Ethical Advisory Committee 
approved the study.  Daily caffeine intake amongst participants was varied and 
ranged from 30 – 359 mg·day-1.  One participant was characterised as a high 
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user (> 250 mg·day-1), 6 as moderate users (50 – 250 mg·day-1) and 5 as light 
users (< 50 mg·day-1).   
 
Experimental procedures 
Approximately 2 weeks before the beginning of the main trials, each participant 
was required to undertake preliminary measurements including a peakOV 2&  test 
and a familiarisation of the trial protocol.  Preliminary measurements and pre-
trial standardisation procedures are described in Chapter 3.  Participants 
performed 3 main exercise trials, each separated by 1 week.  Participants were 
randomly assigned to either the PLA, 2CAF or 6CAF trial and acted as their 
own controls in a repeated-measures, single-blind, cross-over design.  
Participants arrived at the laboratory at 08:20 h following an overnight fast.  
Participants then ingested 0, 2 or 6 mg·kg-1 body mass of caffeine and rested 
quietly in the laboratory for 1 h.  Immediately after this, participants began 
cycling on an electromagnetically braked cycle ergometer for 90 min at a work 
rate equivalent to 70% peakOV 2&  [213 (22) W]. Venous blood samples were 
obtained at pre-supplement, 1 h after CAF or PLA ingestion (pre-exercise), 
immediately post-exercise and 1 h post-exercise.  Laboratory conditions 
throughout the study were 19.6 (0.5) °C and 35.7 (5.4) % relative humidity.   
 
Blood analytical methods  
Blood sampling and analysis methods are detailed in Chapter 3.6 
 
Statistical analysis 
Statistical methods are detailed in Chapter 3.7 
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6.4. Results 
Exercise intensity, heart rate and indirect calorimetry   
Mean exercise intensity was similar between all trials [PLA: 72.0 (3.2)%, 2CAF: 
72.8 (3.3)%, 6CAF: 73.3 (3.3)%].  Heart rates were comparable between trials 
during exercise [PLA: 155 (9) beat·min-1, 2CAF: 159 (8), 6CAF: 161 (8) 
beat·min-1; mean of all recordings].  RER and fat and CHO oxidation rates did 
not differ between trials throughout exercise [PLA: 0.92 (0.05), 0.45 (0.29) 
g·min-1, 2.67 (0.61) g·min-1; 2CAF: 0.92 (0.06), 0.46 (0.30) g·min-1, 2.69 (0.57) 
g·min-1; 6CAF: 0.92 (0.06), 0.48 (0.29) g·min-1, 2.69 (0.59) g·min-1, for RER, fat 
and CHO oxidation rates, respectively].  Likewise, EE and the percentage 
contribution of fat and CHO were similar on all trials [PLA: 63 (3) KJ·min-1, 27 
(17)%, 73 (17)%; 2CAF: 64 (4) KJ·min-1, 28 (18)%, 72 (18)%; 6CAF: 64 (4) 
KJ·min-1, 29 (18)%, 71 (18)%, for EE and % of fat and CHO, respectively]. 
 
Changes in body mass and plasma volume 
After exercise, change in body mass (corrected for fluid intake) was similar for 
all trials [PLA: -1.5 (0.3) kg, 2CAF: -1.6 (0.3) kg, 6CAF: -1.6 (0.3) kg].  There 
was no significant time x trial interaction effect for changes in plasma volume 
relative to the initial blood sample.  After exercise plasma volume decreased by 
8.2 (5.2)%, 8.0 (5.0)% and 8.5 (5.4)% on the PLA, 2CAF and 6CAF trials, 
respectively. 
 
Serum caffeine concentration 
A significant time x trial interaction was found for serum caffeine concentration 
(P<0.01), with higher concentrations at pre, post and 1 h post-exercise on 6CAF 
compared with PLA and 2CAF (P<0.01; Figure 6.1).  At these times, values on 
2CAF were significantly higher than on PLA (P<0.01; Figure 6.1).   
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Figure 6.1: Serum caffeine concentrations during PLA, 2CAF and 6CAF trials.   
* significantly higher on 6CAF than PLA and 2CAF (P<0.01); ** significantly 
higher on 2CAF than PLA (P<0.01); † significantly higher than pre-supplement 
within trial (P<0.01). Values are means ± SD. 
 
Circulating lymphocyte counts and numbers of CD3-CD56+ cells 
No significant time x trial interaction effect was found for total number of 
circulating lymphocytes but there was a significant main effect for time (P<0.01) 
with the circulating number of lymphocytes following a biphasic response to 
exercise (Table 6.1).  A significant time x trial interaction was found for the 
number of CD3-CD56+ cells within the circulating lymphocyte population, with 
values higher on 6CAF at post-exercise compared with PLA (P<0.01; Table 
6.1). 6CAF also showed a higher number of CD3-CD56+ cells within the 
circulating lymphocyte population than on 2CAF (main effect for trial; P<0.05).  
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Number of unstimulated and antigen-stimulated CD3-CD56+ cells expressing 
CD69  
There were no significant time x trial interaction effects for the number of 
unstimulated or antigen-stimulated CD3-CD56+ cells expressing CD69 for any of 
the trial comparisons.  However, the number of unstimulated and antigen-
stimulated CD3-CD56+ cells expressing CD69 increased above pre-supplement 
values at post-exercise and decreased below baseline at 1 h post-exercise 
(main effect for time: P<0.01; Table 6.1).  
 
Table 6.1: Total lymphocyte count, number of circulating CD3-CD56+ cells and 
number of circulating CD3-CD56+ cells expressing CD69 during PLA, 2CAF and 
6CAF trials. 
   Pre-supplement Pre-exercise Post-exercise    1 h post-exercise 
Total Lymphocytes (x109 cells·L-1)  a 
PLA 2.10 (0.60) 1.70 (0.40) 2.30 (0.80) 1.50 (0.40) 
2CAF 2.10 (0.50) 1.80 (0.40) 2.50 (0.70) 1.50 (0.40) 
6CAF 2.10 (0.60) 1.90 (0.40) 2.70 (1.10) 1.50 (0.40) 
CD3-CD56+ cells (x109 cells·L-1) b, c 
PLA 0.39 (0.17) 0.33 (0.16) 0.62 (0.30) †† 0.28 (0.12) †† 
2CAF 0.42 (0.16) 0.39 (0.15) 0.68 (0.30) 0.25 (0.11) 
6CAF 0.42 (0.24) 0.43 (0.19) 0.79 (0.36) * † 0.31 (0.14) 
CD3-CD56+ CD69+ cells (x106 cells·L-1) b, c 
unstim PLA 39.8 (33.1) 30.2 (23.0) 49.1 (35.0) 20.6 (13.5) 
unstim 2CAF 34.2 (22.8) 31.3 (18.0) 55.5 (45.1) 19.3 (15.3) 
unstim 6CAF 34.4 (19.7) 39.5 (23.9) 65.1 (32.3) 23.9 (14.8) 
1 :4000 PLA 47.7 (22.0) 42.0 (22.2) 82.4 (40.1) 42.1 (24.3) 
1 :4000 2CAF 49.5 (24.0) 65.8 (39.6) 95.4 (63.4) 39.3 (26.1) 
1 :4000 6CAF 53.6 (25.6) 75.8 (70.3) 98.0 (30.7) 41.8 (24.7) 
1 :8000 PLA 37.9 (17.3) 41.5 (23.3) 69.5 (37.4) 26.2 (15.4) 
1 :8000 2CAF 40.7 (20.5) 55.6 (31.1) 75.2 (50.9) 28.2 (25.6) 
1 :8000 6CAF 40.3 (27.4) 61.8 (63.8) 79.0 (45.5) 32.7 (21.9) 
Values are means (SD).    * P<0.05: significantly higher on 6CAF than PLA. 
† P<0.01, †† P<0.05: significantly different than pre-supplement within trial. 
a  Main effect for time: significantly different from pre-supplement at pre-exercise, post-exercise 
and 1 h post-exercise, P<0.01. 
b  Main effect for time: significantly different from pre-supplement at post-exercise and 1 h post-
exercise, P<0.01. 
c Main effect for trial: significantly higher on unstim 6CAF than unstim PLA and unstim 2CAF, 
P<0.05. 
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Geometric Mean Fluorescence Intensity of CD69 expression on unstimulated 
and antigen-stimulated CD3-CD56+ cells 
There was a significant interaction effect for the GMFI of CD69 expression on 
unstimulated CD3-CD56+ cells, with both 2CAF and 6CAF demonstrating a 
significant increase at 1 h post-exercise compared with PLA (both P<0.05; 
Figure 6.2a).  Values on 2CAF also appeared to be higher than on PLA at pre-
exercise; this approached significance (P=0.061).  GMFI of CD69 expression on 
unstimulated CD3-CD56+ cells was also higher on 2CAF than 6CAF (main effect 
for trial, P<0.05; Figure 6.2a).  When cells were stimulated, GMFI of CD69 
expression on antigen-stimulated (1:4000) CD3-CD56+ cells tended to be higher 
on 6CAF than PLA (P for interaction=0.09; Figure 6.2b), while the GMFI of 
CD69 expression on antigen-stimulated (1:8000) CD3-CD56+ cells was 
significantly higher on 2CAF at 1 h post-exercise compared with PLA (P<0.05; 
Figure 6.2c). There were no differences between 2CAF and 6CAF with either 
dose of antigen (Figures 6.2b & c, respectively).   
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Figure 6.2: Geometric Mean Fluorescence Intensity of CD69 expression on (a) 
unstimulated CD3-CD56+ NK cells, (b) 1:4000 antigen-stimulated CD3-CD56+ 
NK cells, (c) 1:8000 antigen-stimulated CD3-CD56+ NK cells within the 
circulating lymphocyte population during PLA, 2CAF and 6CAF trials.                 
* significantly higher than PLA (P<0.05); † significantly higher than pre-
supplement within trial (P<0.05). Values are means + SD and are expressed as 
a percentage of pre-supplement value.  
 
6.5. Discussion 
The findings of the present study suggest that, compared with placebo, 
ingesting 2 or 6 mg·kg-1 body mass of caffeine 1 h prior to exercise is 
associated with (i) increases in the natural state of activation of circulating NK 
cells and (ii) increases in the GMFI of CD69 expression on antigen-stimulated 
NK cells 1 h following high intensity prolonged cycling.  The effects of caffeine 
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on NK cell activation 1 h after prolonged intensive cycling were not found to be 
dose-dependent.  Also, only a large dose of caffeine (6 mg·kg-1) increased the 
trafficking of NK cells into the peripheral circulation immediately post-exercise 
compared with placebo.   
 
In the present study both a high and low dose of caffeine increased 
unstimulated and antigen-stimulated NK cell activation 1 h following 90 min 
cycling at 70% peakOV 2& .  The apparently positive effects of caffeine on NK cell 
activation may be explained through its ability to alter intracellular cAMP. The 
actions of adenosine via A2A adenosine receptors (Priebe et al., 1990) have 
been shown to inhibit NK cell function via activation of adenylate cyclase and 
increased intracellular cAMP concentration (Goto et al., 1983); while the actions 
of adenosine via A1 adenosine receptors have been shown to enhance NK cell 
function via suppression in cAMP (Goto et al., 1983).  It is known that caffeine is 
a non-selective adenosine receptor antagonist.  Therefore, it is suggested that 
both the high and low dose of caffeine acted to impede the adenosine-mediated 
increase in intracellular cAMP concentration in NK cells via antagonism of A2A 
adenosine receptors (Raskovalova et al., 2006).  Although plasma adenosine 
concentration was not measured in this study it has been reported in rats that 
doses of caffeine corresponding to those used in this study increased plasma 
concentrations of adenosine via adenosine receptor blockade in a dose-
dependent manner (Conlay et al., 1997). 
 
Caffeine also has the potential to reduce NK cell function indirectly via its ability 
to increase the release of adrenaline (Graham, 2001). Adrenaline stimulates β2 
adrenoreceptors on NK cells and in turn increases the level of intracellular 
cAMP, leading to an inhibition of NK cell function (Murray et al., 1992).  As both 
caffeine doses in this study increased, rather than decreased, NK cell activation 
1 h after exercise it is unlikely that adrenaline played a principal role on NK cell 
activation here. However, it should be noted that any effect of caffeine on 
antigen-stimulated NK cell activation is most likely the net result of a number of 
stimulatory and inhibitory influences.  Therefore, in the present study it could be 
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argued that A2A adenosine receptor antagonism may have exerted a stronger 
influence on NK cell function than enhanced adrenergic stimulation.  
 
In the present study a high dose of caffeine increased the trafficking of NK cells 
into the circulation immediately after exercise cessation compared with placebo 
(this result was also found in Chapter 5).  Adrenaline is known to modulate the 
expression of adhesion molecules on NK cells, leading to increased 
mobilisation of these cells into the circulation following high intensity exercise 
(Benschop et al., 1996).  With this in mind, an alternative action of caffeine in 
this study might have been to influence an adrenaline-mediated mobilisation 
into the peripheral circulation of a specific population of NK cells with an 
activated phenotype, and/or with increased propensity for activation when 
stimulated.  Although plasma adrenaline concentration was not measured in this 
study, our participants, exercise protocol and serum caffeine concentration 
following exercise on the 6 mg·kg-1 caffeine dose are comparable with those of 
Walker et al. (2006); who found a significantly higher plasma adrenaline 
concentration following exercise with 6 mg·kg-1 caffeine compared with placebo 
(present study: 44 µM; Walker et al.: 46 µM).  While high doses of caffeine (6 & 
9 mg·kg-1) appear to increase plasma concentrations of adrenaline, it has been 
reported that a low caffeine dose (3 mg·kg-1) has little effect at increasing 
plasma adrenaline concentration in response to high intensity exercise (Graham 
and Spriet, 1995).  This may help to explain why in the present study, NK cell 
recruitment into the circulation after exercise was higher on 6CAF, with no 
differences between 2CAF and PLA at this time, and why there was a higher 
overall number of naturally activated NK cells within the peripheral circulation 
with 6CAF compared to PLA and 2CAF.  
  
This study is the first to report apparently positive effects of a low dose of 
caffeine on antigen-stimulated NK cell activation 1 h following high intensity 
exercise.  Furthermore, this study has demonstrated that a low dose of caffeine 
appears to exert similar effects on NK cell activation 1 h following prolonged 
intensive cycling as that of a dose 3 times as large. This is a significant finding 
as many athletes only ingest small amounts of caffeine to enhance athletic 
  83   
   
 
  
 
performance (Chester and Wojek, 2008) and suggests that a low dose of 
caffeine as well as being ergogenic (Cox et al., 2002) may also have the 
potential to strengthen an athlete’s first line of defence against infectious agents 
following high intensity exercise.  However, it is difficult to extrapolate an 
enhancement in NK cell activation to an enhancement of an athlete’s overall 
immunity 1 h following high intensity exercise; the enhancement in this study 
relates to one particular cellular response and as such may not accurately 
represent what is happening to the rest of the athlete’s immune system.  Future 
use of in vivo cell-mediated immune function tests would help shed light on any 
effect of caffeine ingestion on whole body cell-mediated immunity. 
 
Although in this study the effects of ingesting 6 mg.kg-1 caffeine on antigen-
stimulated NK cell activation did not reach statistical significance, it showed a 
trend for increased cellular responses that was comparable to that observed 
with ingestion of 2 mg.kg-1 caffeine.  Data described in Chapter 5 demonstrated 
that a 6 mg.kg-1 body mass dose of caffeine was effective at increasing antigen-
stimulated NK cell activation following an identical exercise protocol.  The 
present participants are comparable to those used in Chapter 5 and diet, 
exercise and caffeine controls before the trial were identical to the former study.  
However, inter-individual variations in responses were greater here than in 
Chapter 5.  This may relate to individual differences in habitual caffeine intake; 
as caffeine consumption here was more varied among the participants than in 
the previous study. Indeed, large inter-individual differences in athlete’s 
physiological and performance responses to the effects of caffeine have been 
reported (Desbrow et al., 2009; Skinner et al., 2010).  Future investigations into 
the effects of caffeine on specific groups of caffeine users, i.e. light, moderate or 
high users, would help clarify reasons for such variability. 
 
In conclusion, the findings of the present study suggest that both a high and low 
dose of caffeine are associated with an increase in the natural state of 
activation of NK cells, in addition to positive effects on antigen-stimulated NK 
cell activation 1 h following high intensity prolonged cycling.  However, there 
was no obvious effect of caffeine dose on these responses. It is suggested that 
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these findings reflect an overriding A2A antagonistic effect of caffeine.  Despite 
both doses of caffeine having a positive influence on NK cell activation 1 h 
following high intensity exercise the clinical significance of these findings in 
terms of subsequent infection risk are as yet unclear.  
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 Chapter 7 
 
 
 
 
 
 
       Effect of a single and repeated dose of caffeine 
 on antigen-stimulated human natural killer cell 
 activation after high intensity intermittent  
 exercise 
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7.1. Abstract 
Several studies including those in Chapters 5 and 6 that have investigated the 
effect of caffeine on immune function following exercise have tended to use one 
large bolus dose of caffeine.  However, this does not model typical caffeine 
consumption.  Therefore, the purpose of this study was to investigate whether 
small repeated doses of caffeine ingested throughout the day would elicit a 
similar response as one large bolus dose ingested 1 h prior to exercise 
compared with placebo on antigen-stimulated NK cell activation following 
strenuous intermittent exercise.  In a randomised cross-over design, 15 healthy 
male games players [age: 22 (2) years, max2OV& : 54 (3) ml·kg-1·min-1, mean ± 
SD] completed six 15 min blocks of intermittent running consisting of maximal 
sprinting interspersed with less intense running and walking.  Participants had 
ingested either 0 (PLA), 2 mg·kg-1 body mass caffeine on 3 separate occasions 
during the day (3x2CAF) or 1 dose of 6 (6CAF) mg·kg-1 body mass caffeine, 1 h 
before exercise.  Whole blood was stimulated with Pediacel (5 in 1) vaccine.  At 
1 h post-exercise the number of antigen-stimulated CD3-CD56+ cells expressing 
CD69 was significantly lower on the 6CAF trial than PLA [P<0.05; PLA: 41.96 
(33.99) x106 cells·L-1 vs. 6CAF: 26.21 (25.04) x106 cells·L-1], with values on 
6CAF at this time-point remaining close to pre-supplement.  6CAF also tended 
to attenuate the exercise-induced increase in the GMFI of CD69 expression on 
antigen-stimulated CD3-CD56+ cells 1 h post-exercise [P=0.055; PLA: 141 
(28)% vs. 6CAF: 119 (20)%].  These findings suggest that one large bolus dose 
of caffeine attenuates the exercise-induced increase in antigen-stimulated NK 
cell activation 1 h following strenuous intermittent exercise, while small repeated 
doses of caffeine ingested throughout the day have little effect on NK cell 
activation.  However, this attenuation at no point fell below pre-supplement 
values and as such caffeine does not appear to depress NK cell activation.   
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7.2. Introduction 
Despite the reported widespread and frequent use of caffeine within society 
(Heatherley et al., 2006), very few studies have investigated the effect of 
caffeine on immune cell responses to exercise in healthy individuals.  Of the 
handful of studies that have been published, all have administered 6 mg·kg-1 
body mass caffeine in one bolus dose following a 60 h abstinence period 
(Bishop et al., 2005a, 2006b; Walker et al., 2006, 2007, 2008). However, 
caffeine is typically consumed in separate doses throughout the day, following 
an overnight abstention (Fredholm et al., 1999).  To the author’s knowledge no 
study to date has attempted to model natural caffeine consumption in terms of 
dose and time of consumption when investigating caffeine’s effects on immune 
cell function following exercise.  Results in Chapter 6 demonstrate that a small 
dose of caffeine (2 mg·kg-1) ingested 1 h prior to exercise increases antigen-
stimulated NK cell activation 1 h following high intensity cycling to the same 
extent as that of a dose 3 times as large (6 mg·kg-1).  Therefore the aim of this 
study was to investigate whether small repeated doses (2 mg·kg-1) of caffeine 
ingested throughout the day (9:00 h, 12:00 h & 15:00 h) would elicit a similar 
response as one large (6 mg·kg-1) bolus dose ingested 1 h prior to exercise 
(15:00 h) compared with placebo on antigen-stimulated NK cell activation 
following 90 min of high intensity intermittent exercise, as assessed by the early 
activation marker CD69. 
 
Caffeine has been shown to increase sympathoadrenal medullary system 
(SAM) activity and as such plasma adrenaline concentration (reviewed in 
Graham, 2001).  Salivary α-amylase activity is stimulated by increased activity 
of the sympathetic nervous system (Rohleder et al., 2004).  Therefore, it has 
been suggested that elevations in α-amylase concentration can be considered a 
good indicator of enhanced sympathetic activity (Anderson et al., 1984; 
Rohleder et al., 2004).  As such salivary α-amylase has been chosen as a 
surrogate marker for plasma adrenaline concentration in the present study.  
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7.3. Methods 
Participants 
Fifteen healthy male games players [age: 22 (2) years; body mass: 76 (8) kg; 
max2OV& : 54 (3) ml·kg-1·min-1] volunteered to participate in this study.  All 
participants were fully informed about the rationale for the study and the design 
of the exercise tests and trial protocol, along with their possible risks and 
discomforts, before providing written informed consent.  Loughborough 
University Ethical Advisory Committee approved the study.  All participants 
were moderate caffeine users (50 – 250 mg·day-1), with an average daily 
caffeine intake of 159 (61) mg·day-1. 
 
Preliminary testing 
Approximately 2 weeks before the beginning of the main trials, each participant 
was required to perform a progressive shuttle run test to volitional fatigue to 
estimate maximal oxygen consumption ( max2OV& ) (Ramsbottom et al., 1988). 
From this estimate, running speeds corresponding to 55% and 95% max2OV&  
were calculated from the tables for predicted max2OV&  values (Ramsbottom et al., 
1988).  Participants came back into the lab on a separate occasion to undertake 
a familiarisation trial, which required them to perform 3x15 min blocks (45 min) 
of the LIST (Nicholas et al., 2000).  Heart rates (Polar FS1, Polar Electro Oy, 
Kempele, Finland) were monitored continuously during the familiarisation trial.  
 
Experimental trial procedures 
Participants were instructed to stop consuming caffeine from 21:00 h the night 
before each trial.  In order to standardise nutritional status, participants 
completed a 24 h food diary the day before and day of the first main trial and 
were asked to follow these diaries for the second and third main trials.  
Participants performed 3 main exercise trials, each separated by 1 week.  
Participants were randomly assigned to either the PLA, 6CAF (1 single dose of 
6 mg·kg-1 caffeine) or 3x2CAF (3 repeated doses of 2 mg·kg-1 caffeine) trial and 
acted as their own controls in a repeated-measures, single-blind, cross-over 
design.  Participants arrived at the laboratory at 08:50 h following an overnight 
fast of 12 h.  After 10 min of resting quietly an initial (pre-supplement) blood 
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sample was obtained from an antecubital forearm vein by venepuncture.  
Following the blood sample, an initial (09:00 h, pre-supplement) saliva sample 
was obtained.  Participants then ingested 0 (PLA & 6CAF) or 2 (3x2CAF) 
mg·kg-1 body mass of caffeine.  For the 0 mg·kg-1 dose, participants ingested 2 
mg·kg-1 body mass of dextrose powder.  Participants then rested quietly in the 
laboratory for 1 h before a further (10:00 h) saliva sample was taken, after 
which participants were free to leave the laboratory and to start eating.  
Participants were required to return to the laboratory at 12:00 h to ingest 
another set of either 0 (PLA & 6CAF) or 2 (3x2CAF) mg·kg-1 caffeine capsules 
and to provide a further saliva sample (12:00 h).  After the saliva sample 
participants left the laboratory until 15:00 h, at which time they provided another 
saliva sample (15:00 h).  Participants stopped eating from 15:00 h. Participants 
then ingested a final set of either 0 (PLA), 2 (3x2CAF) or 6 (6CAF) mg·kg-1 
caffeine capsules immediately after the saliva sample. Participants then rested 
quietly in the laboratory for 1 h before a further venous blood and saliva sample 
(16:00 h, pre-exercise) were taken. The specific timings of PLA or CAF 
ingestion along with blood and saliva samples are illustrated in Figure 7.1.  
Immediately following venous blood and saliva samples pre-exercise body 
mass (in shorts only) was recorded, after which, participants began six 15 min 
periods of intermittent shuttle running, which consisted of ~10 cycles of walking, 
maximal sprinting, jogging and cruising (Figure 7.2).  Participants were required 
to run between two lines separated by 20 m at various speeds that related to 
previous max2OV&  values. Each 15 min bout of running was separated by a 3 min 
rest period.  During this period participants were allowed to consume water ad 
libitum and were asked to rate their perceived exertion on a Borg 6-20 scale 
(Borg, 1982). Heart rates were recorded prior to, during and immediately after 
each 15 min period of intermittent shuttle running.  A further venous blood and 
saliva sample (17:45 h, post-exercise) were obtained immediately after 
cessation of exercise, before post-exercise body mass (in shorts only) was 
recorded.  Participants then consumed 5 ml·kg-1 body mass of water and rested 
quietly in the laboratory for a further hour before a final venous blood and saliva 
sample (18:45 h, 1 h post-exercise) was obtained.  During this time no 
additional food or fluid was administered to participants.  For all saliva samples, 
participants were asked to swallow to empty the mouth before timed 
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unstimulated whole mixed saliva collections were made into pre-weighed sterile 
vials (7 ml capacity bijou tubes with screw-top). All collections were made over 
a 2 min period, unless insufficient volume had been produced, in which case the 
collection period was increased to 3 min, as necessary.  All collections were 
made with participants seated; leaning forwards and with their heads tilted 
downwards.  Participants were instructed to allow the saliva to dribble into the 
tube with minimal orofacial movement.  Laboratory conditions throughout the 
study were 20.5 (0.9) °C and 42.2 (6.9) % relative humidity.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
  
 
 
 
 
 
 
 
 
Figure 7.1: Schematic representation of the trial protocol 
 
 
 
 
 * *   * 
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Blood sample 
Saliva sample 
        Pre-supplement                                                                               Pre-exercise         Post-exercise      1 h post-exercise 
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Figure 7.2: Schematic representation of the Loughborough Intermittent Shuttle 
Test (LIST).  Adapted from Nicholas et al. 2000. 
 
 
 
 
Lymphocyte culture 
Due to the large time gap (6 h) between pre-supplement and pre-exercise 
venous blood samples, 2 lots of cultures were set up: one set was the pre-
supplement sample; the other set was the pre-exercise, post-exercise and 1 h 
post-exercise samples.  All cell culture work was carried out in a class II laminar 
flow hood (Esco GB Ltd, Salisbury, UK) by using aseptic techniques.  Blood 
sampling and analysis methods are detailed in Chapter 3.6. 
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Saliva flow rate 
Saliva samples were stored in their plastic containers at –80 °C prior to 
analysis. Saliva volume was estimated by weighing the bijou tubes to the 
nearest mg before and after saliva collection. Saliva density was assumed to be 
1.00 g.ml-1 (Cole and Eastoe, 1988) and from this, the saliva flow rate (µl·min-1) 
was determined by dividing the volume of saliva by the collection time.  
 
Saliva α-amylase 
Saliva α-amylase activity was measured using a commercially available kit 
(InfinityTM Amylase Liquid Stable Reagent, Thermo Scientific, UK), with 
proportional reduction of volumes so that the assay could be carried out in a 
microtitration (96-well) plate.  Briefly, 20 µl saliva diluted 1:100 with 1.0 mM 
CaCl2 was mixed with 180 µl of amylase reagent.  The plate was incubated for 1 
min at 25°C and then the increase in absorbance at 405 nm was recorded every 
min for a further 4 min period on an automated plate reader.  Purified α-amylase 
from human saliva (A1031, Sigma) was used as a standard.  The secretion rate 
of α-amylase (U·min-1) was calculated by multiplying the saliva flow rate by the 
α-amylase activity.  The intra assay coefficient of variation for α-amylase was 
1.1%.   
 
Statistical analysis 
Statistical methods are detailed in Chapter 3.7. 
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7.4. Results 
Physiological measurements 
There were no differences in ratings of perceived exertion between trials during 
the test [RPE of 13 (2) for all trials].  Likewise, heart rates were similar between 
trials during exercise [PLA: 171 (12) beat·min-1, 6CAF: 175 (13) beat·min-1, 
3x2CAF: 177 (12) beat·min-1; mean of all recordings]. 
 
Changes in body mass and plasma volume 
After exercise, changes in body mass (corrected for fluid intake) were similar for 
all trials [PLA: -1.8 (0.3) kg, 6CAF: -1.8 (0.3) kg, 3x2CAF: -1.9 (0.4) kg].  There 
was no significant time x trial interaction effect for changes in plasma volume 
relative to the initial blood sample.  After exercise plasma volume decreased by 
3.3 (4.4)%, 3.4 (6.0)% and 4.8 (6.6)% on the PLA, 6CAF and 3x2CAF trials, 
respectively. 
 
Serum and saliva caffeine concentration 
6CAF vs. PLA 
A significant time x trial interaction was found for serum caffeine concentration 
(P<0.01), with higher concentrations at pre (16:00 h), post (17:45 h) and 1 h 
post-exercise (18:45 h) on 6CAF compared with PLA (P<0.01; Figure 7.3).  A 
significant time x trial interaction was also found for saliva caffeine 
concentration (P<0.01), with higher concentrations at post (17:45 h) and 1 h 
post-exercise (18:45 h) on 6CAF compared with PLA (P<0.01; Table 7.1). 
3x2CAF vs. PLA 
A significant time x trial interaction was found for serum caffeine concentration 
(P<0.01), with higher concentrations at pre (16:00 h), post (17:45 h) and 1 h 
post-exercise (18:45 h) on 3x2CAF compared with PLA (P<0.01; Figure 7.3).  A 
significant time x trial interaction was also found for saliva caffeine 
concentration (P<0.01), with higher concentrations at 10:00 h, 12:00 h, 15:00 h 
and pre (16:00 h), post (17:45 h) and 1 h post-exercise (18:45 h) on 3x2CAF 
compared with PLA (P<0.01; Table 7.1).   
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Figure 7.3: Serum caffeine concentrations during PLA, 3x2CAF and 6CAF 
trials.  * significantly higher than PLA (P<0.01).  † significantly higher than pre-
supplement within trial (P<0.01).    Values are means ± SD. 
 
Saliva flow rate 
Saliva flow rate appeared to increase significantly above pre-supplement (9:00 
h) values at 10:00 h, 12:00 h, 15:00 h, pre-exercise, post-exercise and 1 h post-
exercise (main effect for time: all time points P<0.01, except post-exercise 
P<0.05; Table 7.1).  However, when compared against pre-exercise values, 
saliva flow rate fell significantly at post-exercise (main effect for time: P<0.01; 
Table 7.1).  There were no significant effects of trial/treatment. 
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Saliva α-amylase 
6CAF vs. PLA 
A significant time x trial interaction was found for saliva α-amylase activity, 
which was significantly higher at pre-exercise and 1 h post-exercise on 6CAF 
compared with PLA (P<0.05; Table 7.1).  A significant time x trial interaction 
was also found for saliva α-amylase secretion rate, which was higher at 1 h 
post-exercise on 6CAF compared with PLA (P<0.05; Table 7.1).   
3x2CAF vs. PLA 
A significant time x trial interaction was found for saliva α-amylase activity, 
which was significantly higher at pre-exercise and 1 h post-exercise on 3x2CAF 
compared with PLA (P<0.05; Table 7.1).  There was no such interaction effect 
for saliva α-amylase secretion rate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 7.1: Saliva caffeine concentration, flow rate, α-amylase activity and secretion rate during PLA, 3x2CAF and 6CAF trials. 
 09:00 h 10:00 h 12:00 h 15:00 h 16:00 h 17:45 h 16:45 h 
                     (Pre-supplement)                           (Pre-exercise)       (Post-exercise)        (1 h post-exercise) 
Saliva caffeine concentration (µmol·L-1) 
PLA 1 (1) 1 (1) 1 (1) 1 (1) 0 (0) 0 (0) 0 (0) 
3x2CAF 1 (1) 10 (4) * † 8 (2) * † 14 (3) * † 15 (3) * † 20 (5) * † 19 (4) * † 
6CAF 1 (1) 0 (0) 0 (0) 1 (1) 2 (2) 30 (4) * † 27 (4) * † 
Saliva flow rate (µl·min-1) a, b 
PLA 441 (268) 549 (252) 543 (180) 567 (203) 572 (200) 484 (171) 683 (248) 
3x2CAF 431 (216) 571 (254) 586 (185) 591 (294) 585 (252) 467 (209) 656 (286) 
6CAF 423 (241) 575 (240) 546 (203) 566 (165) 642 (223) 520 (203) 698 (225) 
Saliva α-amylase activity (U·ml-1) 
PLA 392 (257) 439 (243) 793 (416) 967 (373) 827 (373) † 1456 (530) † 867 (494) † 
3x2CAF 306 (271) 608 (346) 845 (319) 936 (316) 997 (313) * † 1719 (527) † 1098 (430) * † 
6CAF 368 (299) 545 (290) 905 (442) 925 (345) 1023 (369) ** † 1615 (457) † 1196 (402) ** † 
Saliva α-amylase secretion rate (U·min-1) 
PLA 174 (167) 234 (150) 444 (284) 569 (433) 487 (323) † 695 (343) † 580 (391) † 
3x2CAF 138 (151) 239 (291) 526 (353) 570 (357) 587 (357) † 810 (470) † 742 (452) † 
6CAF 157 (154) 314 (192) 497 (293) 494 (188) 660 (327) † 812 (338) † 804 (289) ** † 
Values are means (SD).  n = 6 for saliva caffeine concentration. 
* P<0.01, ** P<0.05: significantly higher than PLA,   
† P<0.01: significantly higher than pre-supplement within trial,   
a Main effect for time; significantly higher than pre-supplement at all other time-points, all P<0.01 except for post-exercise P<0.05,    
b Main effect for time; significantly lower than pre-exercise at post-exercise, P<0.01. 
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Circulating lymphocyte counts and numbers of CD3-CD56+ cells 
6CAF vs. PLA 
At immediately post-exercise, the number of circulating lymphocytes was 
significantly higher compared with pre-supplement on both PLA and 6CAF trials 
(both P<0.01; Table 7.2).  A significant time x trial interaction was found for the 
number of CD3-CD56+ cells within the circulating lymphocyte population 
(P<0.01), with a higher number of CD3-CD56+ cells found at post-exercise on 
6CAF compared with PLA (P<0.01; Table 7.2).     
3x2CAF vs. PLA 
There was a main effect for time for the number of circulating lymphocytes, with 
values increasing above pre-supplement at immediately post-exercise (P<0.01; 
Table 7.2).  A significant time x trial interaction was found for the number of 
CD3-CD56+ cells within the circulating lymphocyte population (P<0.01), with a 
higher number of CD3-CD56+ cells found at post-exercise on 3x2CAF compared 
with PLA (P<0.05; Table 7.2).     
 
Table 7.2: Number of circulating lymphocytes and CD3-CD56+ cells within the 
circulating lymphocyte population during PLA, 3x2CAF and 6CAF trials. 
 Pre-supplement Pre-exercise Post-exercise 1 h post-exercise 
Total Lymphocytes (x109 cells·L-1) a 
PLA 2.10 (0.50) 2.10 (0.50) 2.90 (0.80) † 2.10 (0.50) 
3x2CAF 2.10 (0.70) 2.00 (0.50) 3.10 (1.00) 1.90 (0.50) 
6CAF 2.10 (0.40) 2.10 (0.40) 3.20 (0.80) † 1.90 (0.60) 
CD3-CD56+ cells (x109 cells·L-1) 
PLA 0.26 (0.08) 0.30 (0.09) 0.53 (0.16) † 0.25 (0.07) 
3x2CAF 0.28 (0.09) 0.35 (0.10) †† 0.70 (0.22) ** † 0.25 (0.07) 
6CAF 0.29 (0.11) 0.36 (0.09) †† 0.80 (0.32) * † 0.27 (0.09) 
Values are means (SD). 
significantly higher than PLA, * P<0.01 ; ** P<0.05. 
significantly higher than pre-supplement within trial, † P<0.01 ; †† P<0.05. 
a main effect for time; significantly higher than pre-supplement at post-exercise, P<0.01. 
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Number of unstimulated and antigen-stimulated CD3-CD56+ cells expressing 
CD69 
6CAF vs. PLA 
There were no interaction effects for the number of unstimulated CD3-CD56+ 
cells expressing CD69.  However there was a main effect for time (P<0.01) with 
the number of CD3-CD56+ cells expressing CD69 increasing significantly above 
pre-supplement values at pre and post-exercise, only to fall below pre-
supplement values at 1 h post-exercise (pre-exercise P<0.05; post & 1 h post-
exercise P<0.01; Figure 7.4a).  When cells were stimulated there was a 
significant time x trial interaction effect (both doses; P<0.01), with the number of 
antigen-stimulated CD3-CD56+ cells expressing CD69 lower at 1 h post-exercise 
on 6CAF compared with PLA; values on 6CAF at this time-point remained close 
to pre-supplement (P<0.05; Figure 7.4b & c).   
3x2CAF vs. PLA 
There were no interaction effects for the number of unstimulated CD3-CD56+ 
cells expressing CD69.  However there was a main effect for time (P<0.01) with 
the number of CD3-CD56+ cells expressing CD69 increasing significantly above 
pre-supplement values at pre and post-exercise, only to fall below pre-
supplement values at 1 h post-exercise (pre-exercise P<0.05; post & 1 h post-
exercise P<0.01; Figure 7.4a). There were also no interaction effects when cells 
were stimulated (both doses; Figure 7.4b & c), but there was a main effect for 
time (P<0.01), with the number of CD3-CD56+ cells expressing CD69 increasing 
significantly above pre-supplement values at pre, post and 1 h post-exercise (all 
P<0.01 except 1:8000 pre-exercise P<0.05).   
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Figure 7.4: Number of (a) unstimulated CD3-CD56+ NK cells, (b) 1:4000 
antigen-stimulated CD3-CD56+ NK cells, (c) 1:8000 antigen-stimulated CD3-
CD56+ NK cells expressing CD69 within the circulating lymphocyte population 
during PLA, 3x2CAF and 6CAF trials.  * significantly lower than PLA (P<0.05);   
† significantly higher than pre-supplement within trial (P<0.01). Values are 
means + SD. 
 
 
 
 
 
 
 
(c) 
† 
  † 
   † 
  * 
CD
3-
CD
56
+
 
CD
69
+
 
ce
lls
 
(x1
06
 
c
el
ls
·
L-
1 ) 
 102 
 
Geometric Mean Fluorescence Intensity of CD69 expression on unstimulated 
and antigen-stimulated CD3-CD56+ cells 
6CAF vs. PLA 
There were no significant interaction effects for the GMFI of CD69 expression 
on unstimulated CD3-CD56+ cells.  However there was a main effect for time 
(P<0.01), with the GMFI of CD69 expression on unstimulated CD3-CD56+ cells 
increasing significantly above pre-supplement values at 1 h post-exercise 
(P<0.01; Figure 7.5a).  When cells were stimulated there was a significant time 
x trial interaction effect, with the GMFI of CD69 expression on antigen-
stimulated (1:8000) CD3-CD56+ cells increasing on both trials above pre-
supplement values at 1 h post-exercise (P<0.01; Figure 7.5c).    However, 
values tended to be lower on 6CAF compared with PLA at this time (P=0.055; 
Figure 7.5c).  The GMFI of CD69 expression on antigen-stimulated (1:8000) 
CD3-CD56+ cells was also lower at immediately post-exercise on 6CAF 
compared with PLA, with values on 6CAF at this time-point remaining close to 
pre-supplement values (P<0.05; Figure 7.5c).   
3x2CAF vs. PLA 
There were no significant interaction effects for the GMFI of CD69 expression 
on unstimulated or antigen-stimulated (both doses) CD3-CD56+ cells.  However 
there was a main effect for time (P<0.01), with the GMFI of CD69 expression on 
unstimulated CD3-CD56+ cells increasing significantly above pre-supplement 
values at 1 h post-exercise (P<0.01; Figure 7.5a), and at pre-exercise, post-
exercise and 1 h post-exercise on antigen-stimulated (both doses) CD3-CD56+ 
cells (P<0.01; Figure 7.5b & c). 
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Figure 7.5: Geometric Mean Fluorescence Intensity of CD69 expression on (a) 
unstimulated CD3-CD56+ NK cells, (b) 1:4000 antigen-stimulated CD3-CD56+ 
NK cells, (c) 1:8000 antigen-stimulated CD3-CD56+ NK cells within the 
circulating lymphocyte population during PLA, 3x2CAF and 6CAF trials.             
* significantly lower than PLA (P<0.05); † significantly higher than pre-
supplement within trial (P<0.01). Values are means + SD and are expressed as 
a percentage of the pre-supplement value. 
 
7.5. Discussion 
The main findings of this study suggest that exercise induced an increase in the 
number of antigen-stimulated NK cells expressing CD69 as well as in the GMFI 
of CD69 expression on antigen-stimulated NK cells 1 h following 90 min shuttle 
running that was attenuated after consuming one large bolus dose (6 mg·kg-1) 
of caffeine 1 h before exercise (15:00 h; 6CAF).  In contrast, ingesting small 
doses (2 mg·kg-1) of caffeine throughout the day to model a more typical pattern 
(c) 
 * 
   † 
   † 
   † 
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of caffeine consumption (09:00 h, 12:00 h & 15:00h; 3x2CAF) had little effect on 
antigen-stimulated NK cell activation.  
 
It could be suggested that the large bolus dose of caffeine attenuated the 
exercise-induced increase in NK cell activation following high intensity shuttle 
running via stimulating the release of adrenaline.  Adrenaline stimulates β2-
adrenoreceptors found on NK cells, leading to an increase in intracellular cAMP 
levels.  An increase in the concentration of cAMP in the cell may have interfered 
with signals that are necessary for adhesion strengthening (Benschop et al., 
1997) and as such could have preferentially mobilised a less active subset of 
NK cells into the circulation following exercise.  Adrenaline has also been 
shown to inhibit CD69 expression on mitogen-stimulated NK cells (Shimamiya 
et al., 2003) and as such may have been responsible for the lower number of 
antigen-stimulated NK cells expressing CD69 and GMFI expression of CD69 on 
antigen-stimulated NK cells following the large single dose caffeine trial 
compared with placebo 1 h following high intensity shuttle running.  
 
It has been suggested that caffeine’s main mechanism of action is 
predominately via A2A adenosine receptor antagonism (Fredholm et al., 1999).  
As such it was speculated that in the present study both caffeine trials would 
have increased antigen-stimulated NK cell activation in response to exercise 
compared with placebo as previously found in Chapters 5 and 6.  However, this 
was not the case in this study and as such appears to indicate that in the 
present study A2A adenosine receptor antagonism was not the predominant 
mechanism involved.  NK cells also possess A1 adenosine receptors (Priebe et 
al., 1990).  As a non-selective adenosine receptor antagonist, caffeine could 
have antagonised NK cell A1 receptors (Fredholm et al., 1999), which may have 
restricted the increase in antigen-stimulated NK cell activation on both caffeine 
trials in response to high intensity intermittent exercise compared with placebo.   
 
Although plasma adrenaline was not determined in this study, saliva α-amylase 
activity and secretion rate were measured as a surrogate marker, since 
elevations in α-amylase concentration are considered a good indicator of 
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enhanced sympathetic activity (Anderson et al., 1984).  Saliva α-amylase 
activity was significantly higher at 1 h post-exercise on both caffeine trials 
compared with PLA.  However, only the large single dose caffeine trial (6CAF) 
showed a significantly higher α-amylase secretion rate at 1 h post-exercise 
compared with PLA.  As such this may explain why in the present study this 
was the only caffeine trial to attenuate the exercise-induced increase in both the 
number of antigen-stimulated NK cells expressing CD69 and their intensity of 
CD69 expression following high intensity shuttle running.  Large (6 and 9 mg·kg-
1), but not small (3 mg·kg-1), doses of caffeine have been shown to increase 
plasma adrenaline concentration in response to high intensity exercise (Graham 
and Spriet, 1995; Walker et al., 2006).  Therefore, it could perhaps be 
suggested that there may be an adrenaline threshold, above which adrenaline 
produces inhibitory effects upon NK cell activation.  However, as plasma 
adrenaline concentrations were not directly determined in this study, any 
explanation as to how the large bolus dose of caffeine attenuated the exercise-
induced increase in antigen-stimulated NK cell activation following exercise is 
only speculation. 
 
An alternative factor contributing to the contrasting findings reported here and in 
Chapters 5 and 6 may be the issue of caffeine tolerance.  It could be argued 
that as participants were habitual caffeine users, the effects of caffeine on 
antigen-stimulated NK cell activation in response to prolonged high intensity 
exercise in this study may have resulted from participants’ tolerance to the 
effects of caffeine.  It has been demonstrated that tolerance to some of the 
effects of caffeine can develop quite quickly in habitual caffeine users (reviewed 
in Fredholm et al., 1999), yet resensitisation to caffeine usually occurs within 
48-72 h of abstention (Benowitz et al., 1995; Varani et al., 2005).  Studies both 
in rats and humans suggest that following chronic caffeine intake (~14 days) A1 
and A2A adenosine receptors are upregulated leading to an increased sensitivity 
to adenosine (Johansson et al., 1997; Varani et al., 2005).  Therefore, as 
participants were only required to abstain from caffeine overnight (as opposed 
to 60 h in Chapters 5 and 6), caffeine habituation may have contributed towards 
the findings that one large bolus dose of caffeine attenuated the exercise-
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induced increase in antigen-stimulated NK cell activation 1 h following high 
intensity shuttle running yet small repeated doses of caffeine had little effect at 
all.  It should be noted that the mechanisms discussed here are unlikely to 
occur exclusively; therefore these findings are likely to be the net result of 
several positive and negative influences. 
 
The mode of exercise in the present study was also different to that used in 
Chapters 5 and 6 (intermittent running and continuous cycling, respectively) and 
may have influenced caffeine metabolism and as such caffeine’s effects.  
However, this seems unlikely as Graham and Spriet (1991) have reported no 
difference in caffeine metabolism or plasma adrenaline concentration between 
running and cycling to exhaustion. In addition, serum caffeine concentrations 
immediately following 90 min continuous cycling (Chapter 5) and intermittent 
running (present study) with prior ingestion of 6 mg·kg-1 body mass caffeine 
showed comparable values (continuous cycling, 44 µM; intermittent running, 43 
µM). In the present study participants ingested caffeine in a fed state (as 
opposed to a fasted state that occurred in Chapters 5 and 6).  In the present 
study serum caffeine concentrations were very low 1 h after ingesting 6 mg·kg-1 
caffeine when compared to the concentrations achieved at the same time-point 
in Chapters 5 and 6 (present study, 13 µM; Chapter 5, 50 µM and Chapter 6, 43 
µM). Skinner et al. (2010) have also reported lower plasma caffeine 
concentrations 1 h after ingesting 6 mg·kg-1 caffeine with pre-exercise feeding 
(22 µM).  At present the effects of consuming a meal on the absorption and 
appearance of caffeine in serum/plasma are not clear.  However, pre-exercise 
feeding may have the potential to slow gastric emptying, which has been shown 
to regulate caffeine absorption (Higaki et al., 2008), and as such delay the 
absorption of caffeine.  However at 1 h post-exercise, where the difference in 
findings between the present study and Chapters 5 and 6 are apparent, serum 
caffeine concentrations were at comparable values (present study, 40 µM; 
Chapter 5, 47 µM and Chapter 6, 40 µM), suggesting that differences in caffeine 
metabolism in a fed vs. fasted state may effect time to peak serum caffeine 
concentration but have little effect upon overall caffeine metabolism.   
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One limitation of this study was the absence of a resting trial to determine if 
caffeine acted on antigen-stimulated NK cell activation without the influence of 
exercise.  However, data described in Chapter 4 that looked at NK cell 
responses to caffeine at rest between 08:30 h and 12:00 h suggests that 
caffeine at doses of 2 or 6 mg·kg-1 body mass ingested in one bolus dose at 
08:30 h have little effect on antigen-stimulated NK cell activation up until 12:00 
h.  McFarlin et al. (2003) have demonstrated that NKCA as measured with a 
whole blood 51Cr-release assay does not appear to be under any diurnal 
control, as a 24 h period of observation showed no change in NKCA at any 
time-point measured.  As CD69 expression has been shown to be a 
comparable measure of NK cell function as that of NKCA (McFarlin et al., 
2004), it could be suggested that CD69 expression is also unaffected by diurnal 
influences.  
 
In conclusion, the findings of the present study suggest that exercise induced 
an increase in the number of antigen-stimulated NK cells expressing CD69 as 
well as their intensity of CD69 expression 1 h following 90 min shuttle running 
that was attenuated by one large bolus dose (6 mg·kg-1) of caffeine ingested 1 h 
prior to exercise.  In contrast, small doses (2 mg·kg-1) of caffeine ingested 
throughout the day to model a more typical pattern of caffeine consumption had 
little effect on antigen-stimulated NK cell activation.  It should be noted that the 
attenuations seen with one large bolus dose of caffeine at no point fell below 
pre-supplement values and as such suggests that caffeine does not depress 
antigen-stimulated NK cell activation following 90 min of high intensity shuttle 
running.  
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8.1. Thesis outline 
This thesis set out to determine whether caffeine has any effect on lymphocyte 
activation in response to prolonged high intensity exercise.  In order to answer 
this a study was first undertaken to ascertain whether caffeine at a high (6 
mg·kg-1) or low (2 mg·kg-1) dose had any effect on T (CD4+ and CD8+) or NK 
(CD3-CD56+) cell activation at rest.  Once caffeine’s effects at rest had been 
established, subsequent studies went on to investigate: 
 
• The effects of a high (6 mg·kg-1) dose of caffeine on T and NK cell activation 
in response to prolonged high intensity continuous cycling. 
 
• The effects of a high (6 mg·kg-1) and low (2 mg·kg-1) dose of caffeine on NK 
cell activation in response to prolonged high intensity continuous cycling. 
 
• The effects of ingesting one large (1x6 mg·kg-1) bolus dose of caffeine 1 h 
prior to exercise and small repeated (3x2 mg·kg-1) doses of caffeine 
throughout the day on NK cell activation in response to prolonged high 
intensity intermittent shuttle running. 
 
8.2. Main findings of this thesis 
• A high dose of caffeine mobilised a greater number of NK cells into the 
peripheral circulation 1 h and 2.5 h following ingestion at rest.  This 
mobilisation did not occur with a low dose of caffeine.   
 
• A high dose of caffeine had little effect on T cell trafficking at rest or in 
response to high intensity continuous cycling.  A low dose of caffeine also 
had no effect at rest. 
 
• Regardless of exercise mode (continuous cycling or intermittent running), a 
high dose of caffeine mobilised a greater number of NK cells into the 
peripheral circulation immediately following prolonged high intensity 
exercise.   
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• A high dose of caffeine is associated with an increased plasma adrenaline 
concentration but not noradrenaline concentration at rest and following 
continuous cycling.   
 
• A low dose of caffeine had no effect on unstimulated or antigen-stimulated T 
or NK cell activation at rest both in terms of the number of cells expressing 
CD69 or their GMFI expression of CD69. 
 
• A high dose of caffeine had no effect on unstimulated or antigen-stimulated 
T cell activation at rest, but appeared to increase the number of antigen-
stimulated NK cells expressing CD69 1 h following caffeine ingestion while 
exerting no effect on the GMFI expression of CD69 on NK cells. 
 
• A high dose of caffeine reduced the number of antigen-stimulated CD4+ cells 
expressing CD69 1 h following continuous exercise, but had little effect on 
CD8+ or NK cells.  A low dose of caffeine also had no effect on the number 
of NK cells expressing CD69 following continuous exercise.  However, 1 h 
following intermittent running a high dose of caffeine ingested in one bolus 
dose attenuated the exercise-induced increase in the number of antigen-
stimulated NK cells expressing CD69.  This effect did not occur in response 
to intermittent exercise when the high dose of caffeine was instead ingested 
in small repeated doses throughout the day. 
 
• Both a high and low dose of caffeine increased the GMFI expression of 
CD69 on unstimulated and antigen-stimulated NK cells 1 h following 
continuous exercise.  However, at 1 h post-exercise a high dose of caffeine 
also reduced the intensity of CD69 expression on antigen-stimulated CD8+ 
cells in response to continuous cycling and tended to attenuate the exercise-
induced increase in CD69 expression on antigen-stimulated NK cells in 
response to intermittent exercise.  This effect did not occur in response to 
intermittent exercise when the high dose of caffeine was again ingested in 
small repeated doses throughout the day. 
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8.3. Caffeine, exercise and lymphocyte mobilisation 
Part of this thesis investigated the effect of caffeine on the mobilisation of 
lymphocyte subsets into the peripheral circulation in response to prolonged high 
intensity exercise; with lymphocyte subsets being classified as either CD4+, 
CD8+ or CD3-CD56+ cells.  Throughout this thesis a high dose of caffeine 
increased the mobilisation of NK cells into the peripheral circulation immediately 
following prolonged high intensity exercise.  It could be suggested that this 
mobilisation was likely due to the higher plasma adrenaline concentration seen 
with this dose of caffeine at this time-point (see previous Chapter discussions) 
 
However, within CD4+, CD8+ and CD3-CD56+ cells a number of further subsets 
exist with distinct functional and migratory capabilities (Fabbri et al., 2003; 
Fehniger et al., 2003; Campbell et al., 2009).  As such, distinct lymphocyte 
subsets may be recruited into the circulation differentially.  Indeed, studies have 
shown that lymphocyte subsets with enhanced cytotoxic functions and tissue 
migrating potential, such as CD8+ effector memory and NKdim cells are 
preferentially mobilised into the peripheral circulation in response to acute 
physiological and psychological stress (Bosch et al., 2005; Campbell et al., 
2009). A greater mobilisation of enhanced cytotoxic lymphocytes into the 
circulation in response to stress has therefore been linked to an enhanced 
immune surveillance (Bosch et al., 2005). The proposed mechanism 
responsible for this differential recruitment has been suggested to be via β-
adrenergic stimulation (Bosch et al., 2005), and that CD8+ effector memory and 
NKdim cells appear to express relatively higher levels of β2-adrenoreceptors than 
other CD8+ and NK subsets, making these cells the most sensitive to the effects 
of adrenaline (Bosch et al., 2005; Campbell et al., 2009).  Therefore, it could be 
suggested that in this thesis (Chapters 5, 6 and 7) a high dose of caffeine 
increased the mobilisation of NK cells capable of promoting enhanced immune 
function (Bosch et al., 2005) into the peripheral circulation immediately following 
exercise above that of exercise alone, thereby perhaps leading to a stronger 
host defence system.  
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However, these cells also appear to show the largest egress from the blood 1 h 
following intensive exercise (Timmons and Cieslak, 2008; Turner et al., 2010).  
Although a fall in effector lymphocyte number could lead to a reduced ability of 
the host to defend against pathogens, this fall may more simply reflect a 
trafficking of these cells to sites where they are needed for immune functions 
with no detriment to overall host defence (Timmons and Cieslak, 2008).  
Throughout this thesis caffeine ingestion (regardless of dose or dosing strategy) 
had no effect at altering total lymphocyte counts or lymphocyte subset counts 1 
h following intensive exercise when compared to placebo.  Interestingly though, 
only continuous high intensity exercise showed a significant fall below baseline 
values in both total lymphocyte counts and CD4+ CD8+ and NK cell counts 1 h 
following exercise.  Total lymphocyte and NK cell counts had already returned 
to baseline values at the same time-point when intermittent high intensity 
exercise was performed.    
 
8.4. Caffeine, exercise and lymphocyte activation 
It could be suggested that a high dose of caffeine in this thesis led to an 
enhanced first line of defence immediately following prolonged high intensity 
exercise due to the greater number of mobilised NK cells within the circulation 
at this time-point (Chapters 5, 6 and 7).  However, in order for cells to perform 
their specific immune functions in response to an antigenic challenge, they first 
need to become activated.  Therefore, one would have expected that the 
greater number of NK cells immediately following exercise with a high dose of 
caffeine would have led to a greater number of activated NK cells with a higher 
intensity of expression of activation markers in response to antigen-stimulation; 
this was not the case and as such demonstrates that although there was a rise 
in NK cell number with caffeine ingestion following exercise, this did not 
translate into an increase in NK cell function at this time-point.  Similarly, as 
there were no differences in CD4+, CD8+ and NK cell number 1 h following 
exercise with caffeine ingestion when compared to placebo, one might have 
assumed that caffeine had little effect at altering lymphocyte function at this 
time-point, if cell number were the only measure used to determine this.  
However, as seen throughout this thesis caffeine significantly altered 
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lymphocyte activation in response to antigen stimulation 1 h following high 
intensity exercise both in terms of the number of antigen-stimulated lymphocyte 
cells and in the ability of these cells to become activated in response to antigen.   
 
In this thesis a high dose of caffeine reduced the intensity of CD69 expression 
on CD8+ cells in response to antigen stimulation 1 h following prolonged high 
intensity exercise.  In Chapter 5 it was proposed that the increased plasma 
adrenaline concentration that occurred with a high dose of caffeine may have 
stimulated the β2-adrenoreceptors on these cells, increasing intracellular cAMP 
concentrations and as such reducing the ability of these cells to become 
activated in response to antigen stimulation.  However, if any of the participants 
in this study were carrying the cytomegalovirus (CMV), a common herpes virus 
that is carried by 50-70% of western populations (Turner et al., 2010), their 
previous infection history with this virus could have confounded the above 
finding.  It has been reported that CD8+ effector memory cells that are specific 
for CMV are extremely sensitive to the effects of adrenaline due to their high 
expression of β2-adrenoreceptors (Bosch, 2010).  As such these CMV specific 
CD8+ cells are mobilised into the circulation following both acute stress 
(psychological) and β-agonist infusion to a greater extent than any other CD8+ 
subset (Riddell, 2010).  Therefore if any participant were CMV seropositive, 
these cells could have reduced the ability of the total CD8+ population to 
respond to antigen stimulation with the ingestion of a high dose of caffeine 1 h 
following high intensity exercise and may have masked the true effects of 
caffeine on CD8+ cells in response to high intensity exercise.   
 
This thesis has demonstrated the complex influence of caffeine when it comes 
to its effects on antigen-stimulated lymphocyte subset activation in response to 
prolonged high intensity exercise.  Caffeine doses and dosing strategies have 
been shown to exert immunomodulatory effects that have both increased and 
decreased antigen-stimulated lymphocyte activation mostly 1 h following high 
intensity exercise, as well as exerting no effect at all depending on the 
lymphocyte subset measured (T or NK) and the mode of exercise (continuous 
cycling or intermittent running) performed.  However, some of the effects of 
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caffeine have not been replicated in other studies and so throughout this thesis 
a number of factors have been considered that may help to explain why caffeine 
effects are not always replicated and why caffeine appears to effect antigen-
stimulated lymphocyte activation differently both in terms of caffeine dose and 
exercise undertaken.  Factors covered have included differences in mechanistic 
responses, habitual caffeine intake and caffeine tolerance, as well as potential 
differences between exercise mode and caffeine metabolism.    
 
However, a further factor that needs to be considered is that of genetics.  
Studies in animals and humans have implicated that genetic make-up appears 
to play a role in individual variability in caffeine consumption and in the direct 
effects of caffeine (reviewed in Yang et al., 2010).  Both pharmacokinetic and 
pharmacodynamic polymorphisms have been linked to the differences in 
individuals’ responses to caffeine (Yang et al., 2010).  Most interestingly, 
studies have implicated polymorphisms in adenosine A1 and A2A receptors in 
caffeine response (Yang et al., 2010).  For instance, the adenosine A2A receptor 
single-nucleotide polymorphism (SNP) rs5751876, which has three alleles CC, 
CT and TT, has been implicated in an individual’s sensitivity to the effects of 
caffeine.  It was demonstrated that a greater proportion of individuals with the 
CC genotype who reported themselves as sensitive to the effects of caffeine 
were also the most at risk of caffeine-induced sleep impairment, while a greater 
prevalence of those with the TT genotype who reported being insensitive to 
caffeine’s effects showed no risk for caffeine-induced insomnia (Rétey et al., 
2007).  In light of these studies, it could be suggested that differences in 
genotype on lymphocyte A2A receptors could have influenced the effects of 
caffeine on lymphocyte activation in response to exercise in this thesis, and 
may help to explain why some of the effects of caffeine were not always 
reproduced despite similarities in caffeine dose and exercise protocol.  Indeed, 
there does appear to be a tentative link in this thesis between the number of 
unstimulated CD4+ and NK cells expressing CD69 and an individual’s habitual 
caffeine intake.  Correlations appear to suggest that the number of naturally 
active CD4+ (r= -.714, P<0.05) and NK cells (r= -.809, P<0.01) increases as the 
amount of caffeine habitually consumed decreases.   
 116 
 
8.5. Other potential mechanisms 
Several mechanisms have been explained throughout this thesis as to how 
caffeine may exert its effects on lymphocyte activation in response to prolonged 
high intensity exercise.  However, these may not be the only mechanisms 
responsible for caffeine’s effects and as such there may be a number of other 
mechanisms capable of influencing the overall effects of caffeine on lymphocyte 
activation.  Therefore, other potential mechanisms may include the influences of 
heat shock protein 72 (Hsp72) and β-endorphins.  The effects of β-endorphins 
have been shown to be quite variable on lymphocyte function but generally 
appear to inhibit T cell proliferation but increase NKCA (Pedersen and Hoffman-
Goetz, 2000; Wakao et al., 2000).  Recently it has also been suggested that 
Hsp72 may directly activate NK cells (Multhoff, 2009).  Both Hsp72 and β-
endorphin plasma concentrations have been shown to increase following 
intensive exercise (Pedersen and Hoffman-Goetz, 2000; Whitham et al., 2006) 
and as such may be involved in the temporary modulation of lymphocyte 
function seen both immediately and in the hours following high intensity 
exercise (Gleeson, 2007).  Following the ingestion of 6 mg·kg-1 body mass 
caffeine both the plasma concentration of Hsp72 and β-endorphins have also 
been shown to increase significantly in response to high intensity exercise 
above that of exercise alone (Laurent et al., 2000; Whitham et al., 2006).  
Therefore, as the ingestion of caffeine appears to increase the plasma 
concentration of Hsp72 and β-endorphins in response to high intensity exercise, 
it could be suggested that these increases could have contributed to the 
increase in NK cell activation and decrease in T cell activation seen in this 
thesis 1 h following prolonged high intensity exercise.   
 
However, it should be borne in mind that this thesis used whole blood cultures 
when stimulating cells.  Although whole blood cultures are the closest one can 
get to in vivo conditions in terms of retaining the proximity between leukocytes 
and extracellular milieu (Gleeson, 2007); whole blood cultures make it difficult to 
ascertain whether caffeine directly affected lymphocyte activation or exerted its 
effects on other cells and their receptors or soluble factors within the culture (i.e. 
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monocytes, toll like receptor expression and/or heat shock proteins) that 
subsequently influenced lymphocyte activation. 
 
8.6. Remaining Issues 
The main findings from this thesis have shed light on the effects of caffeine on 
antigen-stimulated lymphocyte activation in response to prolonged high intensity 
exercise.  However, in doing so this thesis has highlighted a number of issues 
that require future research.   
 
Throughout this thesis it has been proposed that any differences between 
caffeine and placebo antigen-stimulated T and NK cell activation in response to 
exercise have been due to caffeine exerting a direct effect upon these cells.  As 
explained above this may not be the case and as such future research should 
look to investigate caffeine’s effects on isolated T and NK cells in vitro in 
response to antigen stimulation following high intensity exercise in order to 
determine whether caffeine does directly influence lymphocyte activation.   
 
This thesis has also speculated as to the mechanisms responsible for the 
effects of caffeine on antigen-stimulated lymphocyte activation in response to 
prolonged high intensity exercise.  In order to determine if these speculated 
mechanisms presented in this thesis are the main pathways responsible for 
caffeine’s effects, future studies should investigate the effects of caffeine (at 
different concentrations) combined with adenosine and/or adrenaline (at 
concentrations likely to occur following high intensity exercise) on antigen-
stimulated lymphocyte activation in vitro.   
 
The findings from this thesis appear to suggest that a high dose of caffeine 
ingested in one bolus dose 1 h prior to exercise exerts differential effects on 
antigen-stimulated NK cell activation depending on whether high intensity 
continuous cycling or high intensity intermittent shuttle running is undertaken.  
These findings were unexpected as caffeine metabolism does not appear to 
differ in response to different exercise modes (Graham and Spriet, 1991).  As 
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such it was suggested that the differences seen between exercise modes could 
have been influenced by the length of time participants were asked to abstain 
from caffeine and as such their potential tolerance to caffeine’s effects.  
Therefore, future studies investigating the potential impact of caffeine 
habituation on the effects of caffeine on antigen-stimulated lymphocyte 
activation in response to both high intensity continuous and intermittent exercise 
may help to explain why these differences occurred in this thesis. 
 
8.7. Limitations of this thesis 
As with any research study there are always going to be factors that could have 
been measured that could have added value to your research findings.  As such 
these factors are what I consider to be the main limitations of my thesis and are 
as follows:    
 
• The effects of a high and low dose of caffeine ingested at 08:30 h on T and 
NK lymphocyte activation at rest were only measured up until 12:00 h and 
as such can only be applied to the findings in Chapters 5 and 6.  There is no 
data on the effect of ingesting small repeated doses of caffeine at 09:00 h, 
12:00 h and 15:00 h or one bolus dose of caffeine ingested at 15:00 h on NK 
cell activation at rest up until 18:45 h.  Therefore, although the findings in 
Chapter 7 are more than likely due to the effect of caffeine in response to 
exercise, it is difficult to ascertain for certain that these effects would not 
have occurred in response to caffeine ingestion without subsequent 
exercise. 
 
• The effect of caffeine on T lymphocyte activation was only measured in 1 of 
the 3 exercise studies in this thesis.  Measuring the effect of a low dose of 
caffeine on T lymphocyte activation in response to continuous cycling as 
well as the effect of one large bolus dose of caffeine and repeated small 
doses of caffeine ingested throughout the day on T lymphocyte activation in 
response to intermittent shuttle running could have strengthened Chapters 6 
and 7.  These findings may have given an insight into how these caffeine 
dosing strategies could have affected the adaptive side of the immune 
 119 
 
system in response to different modes of exercise and if these were 
consistent with or contrasted from the finding that a high dose of caffeine 
reduces T cell activation in response to continuous cycling. 
 
• Plasma catecholamines were only measured in 2 of the 4 studies in this 
thesis. As such this thesis only has plasma catecholamine concentrations for 
a high and low dose of caffeine at rest and a high dose of caffeine in 
response to prolonged high intensity continuous cycling.  Measuring the 
concentration of plasma catecholamines following ingestion of a low dose of 
caffeine in response to continuous cycling as well as following ingestion of 
one large bolus dose of caffeine and small repeated doses of caffeine in 
response to prolonged high intensity intermittent shuttle running could have 
strengthened Chapters 6 and 7.  These measures may have helped to 
clarify whether caffeine-induced adrenaline-mediated mechanisms had any 
influence on the effects seen on NK cell activation in response to exercise in 
Chapters 6 and 7.  
 
• Although CD69 has been shown to be a reliable measure of lymphocyte 
function (Green et al., 2003; McFarlin et al., 2004), this thesis did not 
measure any other downstream functional responses of lymphocytes such 
as T cell proliferation or NKCA.   As such any effects of caffeine on the early 
measure of lymphocyte function (CD69) in response to prolonged high 
intensity exercise reported in this thesis may not have actually affected 
subsequent lymphocyte functions.    
 
8.8. Implications of this thesis 
This thesis is the first to demonstrate the complex actions of caffeine on 
antigen-stimulated T and NK lymphocyte activation 1 h after prolonged intensive 
exercise.  A high dose of caffeine decreases antigen-stimulated T cell activation 
(acquired immunity), while a high and low dose of caffeine increases antigen-
stimulated NK cell activation (innate immunity) following continuous exercise. 
Other studies (Bishop et al., 2006b; Walker et al., 2006, 2007) also report 
immunostimulatory effects of caffeine on aspects of the innate immune system 
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during and following high intensity continuous exercise, suggesting that this 
aspect of immune function is perhaps more susceptible to the beneficial effects 
of caffeine following continuous exercise.  However, a high dose of caffeine 
ingested 1 h prior to exercise also appears to attenuate the exercise induced 
increase in NK cell activation 1 h following high intensity intermittent exercise.  
This attenuation does not occur in response to intermittent exercise when a high 
dose of caffeine (1x6 mg·kg-1) is broken down into small doses and ingested 
throughout the day (3x2 mg·kg-1).   
 
Therefore, based on the caffeine habits of athletes and the findings from this 
thesis, athletes wanting to use caffeine as an ergogenic aid should aim to ingest 
~2 mg·kg-1, as this dose of caffeine not only appears to enhance athletic 
performance (Cox et al., 2002), but also appears to increase the ability of NK 
cells to respond to infectious agents 1 h following high intensity exercise similar 
to that of a dose 3 times as large (6 mg·kg-1).  In order to maximise the potential 
benefits of this dose of caffeine both in terms of enhanced performance and 
improved host defence, athletes should look to abstain from caffeine preferably 
for a period of 60 h.   
 
One potential strategy to overcome the negative effects of caffeine on post-
exercise T cell activation following continuous exercise may be co-ingesting 
caffeine with carbohydrate, given that carbohydrate ingestion prevents post-
exercise falls in antigen-stimulated T cell function (Bishop et al., 2005b).  
Carbohydrate ingestion has little effect on NK cell responses to exercise 
(Nieman et al., 1997), therefore combining with caffeine could maximise the 
benefits of both supplements to immune function, in addition to their ergogenic 
effects.  Another strategy may be to ingest a smaller dose of caffeine (2 mg·kg-1 
), as small doses (~3 mg·kg-1) appear to have little effect at increasing plasma 
adrenaline concentrations in response to high intensity exercise (Graham and 
Spriet, 1995).  Therefore, ingesting a small dose of caffeine could limit the 
negative effects of adrenaline on T cell activation while still allowing caffeine to 
increase NK cell activation.  
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Although caffeine has appeared to exert immunomodulatory effects upon 
antigen-stimulated lymphocyte activation in response to prolonged high intensity 
exercise throughout this thesis, the biological significance of these findings in 
terms of their actual potential to alter an individual’s susceptibility to infection is 
still to be determined, yet the widespread use of caffeine within society and the 
athletic population highlights the need for future investigations in this regard. 
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INFORMED CONSENT FORM  
(to be completed after Participant Information Sheet has been 
read) 
 
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all procedures 
have been approved by the Loughborough University Ethical Advisory 
Committee. 
 
I have read and understood the information sheet and this consent form. 
 
I have had an opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in the study. 
 
I understand that I have the right to withdraw from this study at any stage for 
any reason, and that I will not be required to explain my reasons for 
withdrawing. 
 
I understand that all the information I provide will be treated in strict confidence. 
 
I agree to participate in this study. 
 
 
 
                    Your name 
 
 
 
              Your signature 
 
 
 
Signature of investigator 
 
 
 
                               Date 
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HEALTH SCREEN FOR STUDY VOLUNTEERS         Name or Number   ................. 
 
It is important that volunteers participating in research studies are currently in good health and have 
had no significant medical problems in the past.  This is to ensure (i) their own continuing well-being 
and (ii) to avoid the possibility of individual health issues confounding study outcomes. 
 
Please complete this brief questionnaire to confirm fitness to participate: 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .............................. Yes      No      
(b) attending your general practitioner ..................................... Yes      No      
(c) on a hospital waiting list ..................................................... Yes      No      
 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP   ................................................................ Yes      No      
(b) attend a hospital outpatient department .............................. Yes      No      
(c) be admitted to hospital   ...................................................... Yes      No      
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes      No      
(b) Asthma ................................................................................ Yes      No      
(c) Eczema ................................................................................ Yes      No      
(d) Diabetes .............................................................................. Yes      No      
(e) A blood disorder ................................................................. Yes      No      
(f) Head injury ......................................................................... Yes      No      
(g) Digestive problems ............................................................. Yes      No      
(h) Heart problems .................................................................... Yes      No      
(i) Problems with bones or joints    .......................................... Yes      No      
(j) Disturbance of balance/coordination .................................. Yes      No      
(k) Numbness in hands or feet .................................................. Yes      No      
(l) Disturbance of vision .......................................................... Yes      No      
(m) Ear / hearing problems ........................................................ Yes      No      
(n) Thyroid problems ................................................................ Yes      No      
(o) Kidney or liver problems .................................................... Yes      No      
(p) Allergy to nuts .................................................................... Yes      No      
 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after exercise?  ............. Yes      No      
If YES to any question, please describe briefly if you wish (eg to confirm problem was/is short-
lived, insignificant or well controlled.)  
................................................................................................................................................................... 
   5.    Have you had a cold or feverish illness in the past month?    Yes       No      
   6.    Are you accustomed to vigorous exercise (1-3 hours per week)?    Yes       No                      
 
 
Thank you for your cooperation 
Appendix B 
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Physical Activity Questionnaire 
 
The following questions are designed to give us an indication of your 
current level of physical activity.  
 
Name:         Date:     /      /        
 
Are you currently ENDURANCE TRAINING?  YES         NO        . 
If Yes, how many days each week do you usually train?      
………………………….                   
How many training sessions do you have a day?        
…………………………………                        
    How may minutes does each session last?   …………………………………………..                           
    What is your weekly mileage? …………………………………………..........
                                 
Please break this down according to discipline. E.g. cycle, swim and run 
…………………………………………………………………………………………..                                                                              
Are you involved in any of the following training programmes? 
   Weight training          Interval training         Skills training       . 
If Yes, how many days each week do you usually train?  
………………………………………………………………………………………
…..                                                
    How many minutes does each session last? 
…………………………………………………………………………………………
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CAFFEINE CONSUMPTION QUESTIONNAIRE 
 
Please complete the questionnaire concerning your caffeine usage. List the number 
of times you consume the following substances during a typical day.  Please also 
specify the product you use, E.G. Tea – PG tips. 
 
 Morning Afternoon Evening Night 
COFFEE (Regular 5 oz. Mugs) 
Regular 
Brewed 
    
Percolated     
Espresso (2 
oz. Serving) 
    
Instant     
Decaffeinated     
TEA (Regular 
5 oz mugs) 
    
Hot Chocolate 
(Regular 5 oz 
mugs) 
    
Chocolate 
(Regular Bar) 
    
Chocolate 
Biscuits / 
Cakes / 
Cereals 
    
Chocolate / 
Coffee Dairy 
Products 
    
SOFT DRINKS (330ml Can Size) 
Coke     
Dr Pepper     
Energy 
Drinks (Please 
state which 
ones) 
    
OVER THE COUNTER DRUGS 
Pain Killers 
e.g. Anadin 
(Please state 
which ones) 
    
Pro Plus     
Do you take caffeine prior to exercise? _____________ 
If Yes, How much? ____________________________________________________ 
What do you take? _______________________________________________ 
Why? _________________________________________________________ 
MANY THANKS 
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Health Questionnaire 
 
Please complete the following brief questions to confirm your fitness to participate: 
1) At present do you have any health problems for which you are: 
a) On medication, prescribed or otherwise    YES         NO        .  
b) Attending your general practitioner    YES         NO        .  
 
2) Have you any symptoms of ill health, such as those associated with a cold or other 
common infection?       YES         NO        . 
 
3) Are you presently acting as a subject for any other experiment or research study? 
           
        YES         NO        . 
 
If you have answered yes to any of the above questions please give more details below: 
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………. 
                                                                     
                                                             
Do you want to take part in today’s experiments?     YES         NO        . 
 
Signature:……………………….         Date:………………………….                                                          
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Pediacel Titration Jan 2008    
      
CD4+CD69+  Gated on R1 (total lymphocyte population) 
      
conc final conc % gated MFI GMFI  
0 0 3.56 46.59 30.52  
1:100 1:1000 7.48 187.00 87.52  
1:200 1:2000 7.11 273.55 126.29  
1:400 1:4000 8.06 223.7 109.40  
1:800 1:8000 7.81 272.00 129.02  
1:1600 1:16000 7.86 178.28 82.08  
1:3200 1:32000 6.96 135.56 66.58  
1:6400 1:64000 7.18 103.83 48.96  
      
      
CD8+CD69+  Gated on R1 (total lymphocyte population) 
      
conc final conc % gated MFI GMFI  
0 0 3.19 52.14 36.00  
1:100 1:1000 3.61 79.34 45.84  
1:200 1:2000 5.14 111.24 50.41  
1:400 1:4000 5.37 122.49 51.44  
1:800 1:8000 4.03 133.08 59.04  
1:1600 1:16000 3.36 95.73 50.15  
1:3200 1:32000 2.75 81.34 43.45  
1:6400 1:64000 3.49 70.5 40.45  
      
      
CD3-CD56+CD69+  Gated on R2 (CD3-CD56+ lymphocytes) 
      
conc final conc % gated MFI GMFI  
0 0 40.63 21.72 17.19  
1:100 1:1000 46.92 40.05 24.78  
1:200 1:2000 64.74 55.19 32.36  
1:400 1:4000 64.29 56.76 34.34  
1:800 1:8000 55.63 46.42 28.25  
1:1600 1:16000 47.56 37.06 24.05  
1:3200 1:32000 40.18 37.76 24.62  
1:6400 1:64000 41.24 26.34 19.9  
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Exercise trial without caffeine 
 
 
 
 
 
 
Time-points 
Number of cells on the day 
(out of 30000 counts) 
 
Number of cells after 20 h 
incubation (out of 30000 counts) 
 
CD4+ CD8+ CD3- 
CD56+ 
CD4+ CD8+ CD3- 
CD56+ 
Pre-exercise 14973 
50% 
9369 
31% 
5538 
18% 
14689 
49% 
9876 
33% 
5015 
17% 
Post-exercise 11724 
39% 
10803 
36% 
9861 
33% 
11074 
37% 
10266 
34% 
9349 
31% 
 
 
 
 
 
 
Time-points 
% CD4+ cells expressing CD69 GMFI expression of CD69 
On the 
day 
0 1:4000 1:8000 On the 
day 
0 1:4000 1:8000 
Pre-exercise 0.83 3.16 2.63 4.90 24.53 20.00 45.99 27.59 
Post-exercise 0.60 2.12 1.63 4.84 22.81 20.98 19.84 24.87 
 
 
 
 
 
 
Time-points 
% CD8+ cells expressing CD69 GMFI expression of CD69 
On the 
day 
0 1:4000 1:8000 On the 
day 
0 1:4000 1:8000 
Pre-exercise 2.51 4.59 4.58 7.65 23.81 21.89 31.71 25.00 
Post-exercise 2.41 3.91 3.72 6.99 22.19 22.32 20.78 24.76 
 
 
 
 
 
 
Time-points 
% CD3- CD56+ cells expressing 
CD69 
GMFI expression of CD69 
On the 
day 
0 1:4000 1:8000 On the 
day 
0 1:4000 1:8000 
Pre-exercise 3.10 4.86 5.79 6.90 49.07 42.66 42.51 41.83 
Post-exercise 1.62 3.24 3.38 4.73 33.51 38.05 33.25 36.48 
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Rest trial without caffeine  
 
 
 
 
 
 
Time-points 
% CD4+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 0.38 
 
4.53 
 
2.83 
 
42.75 
 
70.66 
 
45.54 
 
Post-exercise 0.52 
 
5.57 
 
3.94 
 
34.39 
 
67.36 
 
64.16 
 
1 h post-exercise 1.54 
 
7.14 
 
5.24 
 
26.73 
 
66.89 
 
58.30 
 
 
 
 
 
 
 
 
 
Time-points 
% CD8+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 1.44 
 
6.23 
 
2.08 
 
44.96 
 
71.57 
 
35.97 
 
Post-exercise 1.61 
 
8.18 
 
4.39 
 
45.39 
 
73.99 
 
54.05 
 
1 h post-exercise 2.73 
 
9.95 
 
7.04 
 
40.43 
 
78.55 
 
64.52 
 
 
 
 
 
 
 
 
 
Time-points 
% CD3- CD56+ cells expressing 
CD69 
GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 3.06 
 
18.60 
 
6.82 
 
40.96 
 
55.01 
 
44.49 
 
Post-exercise 4.23 
 
21.44 
 
16.20 
 
44.15 
 
68.09 
 
64.96 
 
1 h post-exercise 6.59 
 
20.64 
 
16.02 
 
40.54 
 
63.11 
 
52.88 
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Rest trial with caffeine 
 
 
 
 
 
 
Time-points 
% CD4+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 0.49 
 
3.34 
 
1.14 
 
29.70 
 
68.72 
 
24.84 
 
Post-exercise 1.56 
 
4.06 
 
1.83 
 
21.68 
 
57.30 
 
48.07 
 
1 h post-exercise 0.67 
 
3.11 
 
2.09 
 
23.96 
 
47.79 
 
33.47 
 
 
 
 
 
 
 
 
 
Time-points 
% CD8+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 1.22 
 
5.32 
 
2.08 
 
31.65 
 
60.21 
 
39.09 
 
Post-exercise 1.66 
 
6.25 
 
2.18 
 
26.93 
 
55.54 
 
36.24 
 
1 h post-exercise 1.20 
 
3.24 
 
2.53 
 
32.67 
 
40.21 
 
29.96 
 
 
 
 
 
 
 
 
 
Time-points 
% CD3- CD56+ cells expressing 
CD69 
GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 4.83 
 
12.64 
 
7.00 
 
39.69 
 
55.07 
 
49.09 
 
Post-exercise 5.01 
 
12.06 
 
9.51 
 
40.66 
 
56.10 
 
49.05 
 
1 h post-exercise 4.89 
 
11.23 
 
8.87 
 
38.51 
 
49.61 
 
44.12 
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Exercise trial with caffeine 
 
 
 
 
 
 
Time-points 
% CD4+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 1.71 5.20 3.19 22.04 52.36 40.09 
Post-exercise 2.97 5.01 4.12 23.58 39.21 40.38 
1 h post-exercise 1.30 4.90 5.90 26.80 52.70 59.91 
 
 
 
 
 
 
 
 
Time-points 
% CD8+ expressing CD69 GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 6.89 10.99 7.94 21.13 28.70 22.28 
Post-exercise 8.99 8.32 9.79 21.30 25.14 23.97 
1 h post-exercise 6.01 9.89 10.99 23.45 30.75 29.86 
 
 
 
 
 
 
 
 
Time-points 
% CD3- CD56+ cells expressing 
CD69 
GMFI expression of CD69 
Unstim 1:4000 1:8000 Unstim 1:4000 1:8000 
Pre-supplement 1.89 9.83 6.74 36.37 44.58 39.56 
Post-exercise 5.93 7.38 5.35 34.06 40.95 38.08 
1 h post-exercise 1.64 9.72 8.55 45.83 42.56 50.98 
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